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Adrenomedullin (ADM) is a 52 amino acid vasodilator peptide isolated, in 1993, from
human pheochromocytoma. It has been demonstrated in the adrenal medulla of several
mammalian species, including humans and rats. There have been conflicting results of the
tissue distribution in the adrenal cortex. Hypertension is a complex trait with multiple
genetic and environmental influences. Furthermore, salt-sensitive hypertension is
characterized by a cluster of renal, hormonal, and metabolic derangements that might
favour the development of cardiovascular and renal complications. Therefore the
objective of this study was to investigate the adrenal distribution of ADM as well as to
semi-quantitatively assess the adrenomedullin secretory capacity of the adrenal gland in
the rat model of salt sensitive hypertension.
Fourty-four male weanling rats were divided into 4 experimental groups and placed on a
dietary regimen for 6 weeks viz. Dahl salt sensitive (DSS) rats on a high sodium diet (8%
NaCl), DSS on a normal sodium diet (1% NaCl) matched with normotensive Dahl salt
resistant (DSR) rats on the same dietary treatments.
Blood pressure was monitored by tail-cuff readings and by the end of the six weeks, the
DSS rats developed hypertension with tachycardia irrespective of the diet they were fed.
The normal sodium diet was found to delay the development of hypertension, whilst the
high sodium diet exacerbated the development of hypertension. Kidney weights and heart
weights were greater in DSS rats than DSR rats probably due to their renal pathology or
cardiac hypertrophy.
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Adrenomedullin immunopositivity was found predominantly in the adrenal medulla, and
to varying degrees in the zona glomerulosa and zona reticularis of the adrenal cortex. The
semi-quantitative analysis indicate that there was a 6.3 fold increase in ADM content of
DSS rats compared to the DSR rats, where both consumed the 1% NaCI supplemented
diet (DSR : 5.98 ± 0.3 vs. DSS : 37.85 ± 0.5, P < 0.0001). Similarly, there was a 4.1 fold
increase in the ADM content ofDSS on 8% NaCI compared to the DSR on 8% NaCI diet
(DSR: 18.49 ± 0.5 vs. DSS : 75.13 ± 1.6), which was considered extremely significant.
Dahl salt-sensitive hypertensive rats, on either a normal or high NaCl diet, displayed an
increase in adrenomedullin content, which suggests a possible compensatory role of this
hormone in experimental hypertension. Therefore, the Dahl rat may be considered an
appropriate model for the testing of new therapeutic agents, which may stimulate the
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1. INTRODUCTION
Hypertension, which has been plaguing our generations for thousands of years, can be
traced back as far as the Nei Ching, which is the oldest of the extant medical writings,
where the Yellow Emperor observed, "Hence, if too much salt is in the food, the pulse
hardens, tears make their appearance, and the complexion changes" (Rettig et aI., 1989).
This association of high salt intake and hypertension has been exhaustively documented
for decades, but to date this still proves to be a "disease" affecting numerous communities
leading to increased mortality. Hypertension, which is also referred to as the "silent
killer", as the symptoms of high blood pressure can often go undetected until it is too late,
may lead to strokes and heart attacks which are the main causes of death in South Africa
(Villiers, 1995).
Human essential hypertension appears to be a salt related disease. Societies consuming
low amounts of salt have no hypertension, yet if such people migrate to a society with
high salt intakes, ~30% of them show a significant rise in blood pressure. Similarly,
certain strains of rats develop a significant rise in blood pressure when placed on a high
sodium diet. Thus it is likely that the mechanisms that cause a high NaCI intake to raise
blood pressure in animals are the same mechanisms, that cause a high NaCI diet to raise
blood pressure in susceptible people.
The unique animal model of experimental hypertension developed by Dahl has provided
unequivocal evidence that several environmental stimuli produce hypertension only in the
presence of the appropriate genetic trait. The Dahl salt-sensitive (DSS) rat is ge~etically
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predisposed to become hypertensive, whilst the Dahl salt-resistant (DSR) rat IS
genetically predisposed to resist hypertension when exposed to a high sodium diet.
The human body, however, is essentially a complex of regulatory mechanisms, which is
able to assess the physiological status of the body, and make the required adjustments to
restore the normal state, once it has been disturbed. Over the last couple of decades, the
concept of endocrinology has undergone numerous changes. One important change being
the secretion of peptide hormones from organs not actually referred to as "classical"
endocrine organs. Some organs now referred to as endocrine organs include the brain,
heart, vascular tissue and adipose tissue. With the recent discovery of adrenomedullin
(ADM), this "idealistic" concept of endocrinology has been exponentially revolutionized
due to its ubiquitous nature.
This novel hypotensive peptide, adrenomedullin, was discovered 10 human
pheochromocytoma by monitoring the elevation of cyclic-AMP by Kitamura et al.
(1993). Adrenomedullin has a diverse range of biological actions, which include
vasodilation, cell growth, regulation of hormone secretion and natriuresis. It has been
established as being a ubiquitous regulatory peptide, produced in a great number of cell
types and tissues.
ADM originally identified in the adrenal medulla has binding sites in the adrenal gland,
however, its role in the adrenal medulla is unclear. Studies conducted on the tissue
distribution of adrenomedullin in the adrenal gland have been proven to be rather
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contradictory. Furthermore, no preliminary quantification studies have been implemented
with the specific purpose of assessing the adrenomedullin secreting capacity of the
adrenal glands.
Since the DSS rats has many features in common with human essential hypertension it
therefore, provides a unique experimental model with which to unravel mechanisms
concerning the role of sodium in human essential hypertension, and in this study, the
response of adrenomedullin to increased blood pressure.
Owing to the lack of scientific evidence on the adrenal tissue distribution of
adrenomedullin, this study was designed to shed more light on this topic by using
immunoreactive methods as well as to semi-quantitatively analyze its ADM content in





It has been known for over a century that high arterial pressure lessens life expectancy
and for half that time in most patients the raised pressure and its consequences constitute
the disease (essential hypertension) (Laragh and Brenner, 1990). A more general
operational definition which states that hypertension is that level of blood pressure at
which detection and treatment does more good than harm, offers a new challenge to
define hypertension as a risk factor rather than a pathological condition (Evans and Rose,
1971). The World Health Organization classified hypertension as systolic pressure of 140
mm Hg or greater and diastolic blood pressure of 90 mm Hg or greater. Table 1 shows
the classification system to rank blood pressure values for adults.
Table 1 : Classification system to rank blood pressure values for adults (Tortora and
Grabowski, 1996).
OPTIMAL Less than 120mm Hg Less than 80 mm Hg
NORMAL Less than 130 mm Hg Less than 85 mm Hg
HIGH-NORMAL 130 - 139 mm Hg 85 - 89mmHg
HYPERTENSION 140 mm Hg or greater 90 mm Hg or greater
Stage 1 (mild) 140-159mmHg 90 - 99 mmHg
Stage 2 (moderate) 160 - 179 mm Hg 100 - 109 mm Hg
Stage 3 (severe) 180 - 209 mm Hg 110 - 119 mm Hg
Stage 4 (very severe) 210 mm Hg or higher 120 mm Hg or higher
4
2.1.2 Types and causes of Hypertension
Hypertension, also known as "hardening of the pulse" has been suspected as the
underlying cause for stroke and myocardial infarction. Humans develop hypertension
very spontaneously and approximately 90 - 95% of all cases are primary (essential)
hypertension. The remaining 5 - 10% of cases is secondary hypertension. Hypertension is
a common abnormality in humans, and can be produced by many diseases as reflected in
Table 2.
Table 2: Principal causes of sustained hypertension in humans (Ganong, 1989).
1. Unknown
2. Adrenocortical diseases
a. Hypersecretion of aldosterone (Conn's syndrome)
b. Hypersecretion of other mineralocorticoids (hypertensive form of congenital
virilizing adrenal hyperplasia; 17a - hydroxylase deficiency)
c. Hypersecretion ofglucocorticoids (Cushing's syndrome)
3. Catecholamine-secreting tumors of adrenal medullary or paraganglionic ongm
(pheochromocytoma)
4. Tumors ofjuxtaglomerular cells









Primary (essential) hypertension is of unknown etiology : its diverse hemodynamic and
pathophysiologic derangements are unlikely to result from a single cause
(http://www.geocities.com/CollegeParkIDen/5701/hypertension.htm). Several factors
combine to predispose a person to hypertension, including diet, lack of exercise,
metabolic effects and stress. Heredity is a predisposing factor, but the exact mechanism is
unclear. Environmental factors (eg, dietary Na, obesity, stress) seem to act only in
genetically susceptible persons.
Early in the course of essential hypertension, the blood pressure elevations are
intermittent and there is an exaggerated pressor response to stimuli such as cold and
excitement that produce only a moderate blood pressure elevation in normal individuals
(Ganong, 1989). This suggests that overactive autonomic reactions are responsible for the
arteriolar spasm, and treatment with drugs that block sympathetic outflow markedly
slows the progress of the disease. Later the blood pressure elevation becomes sustained.
The baroreceptor mechanism is "reset" so that the blood pressure is maintained at the
elevated level (Ganong, 1989).
Irvine H. Page, a former director of the Cleveland Clinic Foundation and pioneer in the
study of cardiovascular diseases, developed the "mosaic" theory of hypertension. This
theory suggested that instead of being traceable to a single cause, high blood pressure
resulted from complex interactions of many regulatory systems. Page was also one of the
first scientists to recognize that hypertension was a disease, and was treatable.
6
2.1.3 Salt and hypertension
Excessive dietary salt has long been touted as a primary cause of hypertension. Ancient
predecessors made the association of salt in the diet and hedonistic eating patterns with
apoplexy and hardening of the pulse.
Although many controversies still exist regarding the role of dietary sodium intake in the
pathogenesis of hypertension, it is accepted that there is a strong positive correlation
between sodium intake and hypertension, and even modest dietary sodium excess induces
hypertension in salt-sensitive individuals who are genetically susceptible (Laragh and
Brenner, 1990).
Two international studies (Intersalt and WHO-CARDIAC) were set up to examine the
relationship between salt and hypertension. In the Intersalt study fifty-two centers in 32
countries each recruited 200 subjects in whom sodium intake was estimated from 24-hour
urinary sodium excretion (INTERSALT Cooperative Research Group, 1988). This study
provided both negative and positive data on the salt/blood pressure relationship. It was
concluded from the study that "lower average sodium intake might have a favourable
influence on blood pressure, on change of blood pressure with age, and hence on
cardiovascular mortality."
The other study, WHO-CARDIAC, looked at various other dietary factors in addition to
sodium and potassium excretion, was based on about 10,000 people aged 48-56 years in
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46 communities around the world. Significantly, BP was positively related to sodium
excretion in men and not in the women.
2.1.3.1 Salt Sensitivity
"Salt sensitivity" is defined by the observed changes of arterial pressure as daily salt
intake is changed, which has been called the "chronic pressure-natriuresis relationship"
(Guyton, 1986). It is a common trait in patients with essential hypertension and seems to
have both an inherited and an acquired component (eg. is influenced by aging and renal
insufficiency). Oparil et al. (1989) categorized patients with essential hypertension as salt
sensitive when blood pressure was raised by more than 10% in response to a high salt
diet.
The blood pressure response, for a gIven load of dietary salt, is variable amongst
hypertensives and normotensives. Salt-sensitive hypertensives experience a significant
rise in blood pressure when switching from a low-salt to a high-salt diet compared to the
salt-resistant hypertensives who experience a minimal change in blood pressure.
A genetic sensitivity of blood pressure to alterations in dietary sodium is apparent from
studies in animals and humans (Ely, 1997). The development of animal models
reinforced the concept of varying degrees of salt sensitivity of blood pressure in different
types of hypertension. Dahl et al. (1962) developed the Dahl Sand R rat strains, which
showed marked sensitivity of blood pressure and resistance, respectively, to the ability of
high-salt intake to raise blood pressure.
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Although salt sensitivity and sodium sensitivity of blood pressure are often thought of
interchangeably, considerable evidence suggests that both sodium and chloride must be
provided to fully express salt sensitivity (Laragh and Brenner, 1990). Thus, in animal
models such as the Dahl-S, DOCA-salt and stroke-prone spontaneously hypertensive rat
(SHR-sp), feeding sodium without chloride or chloride without sodium does not raise
blood pressure to the extent that NaCI feeding does (Boegehold and Kotchen, 1991).
2.1.3.2 Some mechanisms suggested in the pathogenesis of salt sensitivity
2.1.3.2.1 Volume
Kotchen et al. (1989) postulated that the observation that the concomitant administration
ofboth sodium and chloride is required for the development of salt sensitive hypertension
may provide a clue to the mechanism of salt sensitivity. Volume mechanisms have been
implicated in the pathogenesis of NaCl-sensitive hypertension in both man and
experimental models, including the Dahl S rat (Overbeck, 1981~ Schackow and Dahl,
1966~ Roman and Osbom, 1987).
Increasing evidence suggest that hypertension in the Dahl S rat is related to an impaired
natriuretic capacity of the kidney and an expanded extracellular fluid volume or plasma
volume on a high NaCI intake (Overbeck, 1981; Roman and Osborn, 1987).
Kotchen et al. (1989) concluded that expansion of the extracellular fluid volume by
dietary NaCI contributes to the pathogenesis of salt sensitive hypertension; and that
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failure of selective sodium loading (without chloride) to increase blood pressure may be
related to a redistribution of sodium between the extacellular and intracellular spaces.
2.1.3.2.2 Neural Activity
There is increasing evidence for the participation of the sympathetic nervous system in
the pathogenesis of salt sensitive hypertension. One proposal suggests that sodium exerts
its hypertensive action by decreasing the affinity of alpha-adrenergic receptors in the
medullary centers, resulting in disinhibition of sympathoinhibitory neurons (Gavras,
1986)
2.1.3.2.3 Renal Hemodynamic Effect of Chloride
Chloride itself may act as a direct renal vasoconstrictor. Schnermann et al. (1976)
concluded that a specific renal hemodynamic effect of chloride, resulting in a decreased
filtration fraction and hence a natriuretic "handicap" might contribute to the expansion of
extracellular fluid volume and hypertension in NaCI-Ioaded animals.
2.1.3.3 Physiological Adaptations to varying Salt intakes
The body copes astonishingly well, at least in the short or medium term, with a huge
range of sodium intake, from less than 10mmol to 400mmol or more (Laragh and
Brenner, 1995).
Known short-term adaptations to a high salt intake include the following: extracellular
fluid (ECF) is expanded; cardiac output is higher; plasma epinephrine, norepinephrine,
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and dopamine fall; glomerular filtration rate (GFR) increases; plasma renin activity
(PRA), angiotensin IT, aldosterone fall; plasma ANP rises; and prostacyclin production
increases (Laragh and Brenner, 1995).
The purpose of these adjustments is presumably to make sure that sodium output equals
intake, to keep body sodium as near as possible to a standard norm, and perhaps to
minimize the amount of disturbance in hemodynamics. There seems to be an impression
that body sodium is kept virtually constant in spite of large changes in sodium intake.
However, the evidence is to the contrary: body sodium is higher on a high sodium intake
than on a low one. It is evident that the level of sodium intake affects many physiological
systems and the question arises, as to whether the control systems of some people on long
term salt intake develop secondary changes which are difficult to reverse (Laragh and
Brenner, 1995).
2.1.3.4 Mechanisms of Sodium Homeostasis
Much has been learned about the mechanisms responsible for the relation between salt
intake and arterial blood pressure (Cowley, 1997). Many known physiologic mechanisms
allow us to respond to increased salt intake. An increase in salt intake results in a
reduction in the activity of the renin-angiotensin-aldosterone system (salt-retaining
hormones) and an increase in the release of atrial natriuretic peptide (salt-losing
hormones).
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Each of these systems interacts in turn with other paracrine systems within the kidney,
such as the kallikrein-kinin system and prostaglandins, which either enhance or buffer the
responses (Laragh and Brenner, 1995). In addition, an increase in salt intake results in a
reduction in the sympathetic nerve activity to the kidneys. The net effect of these
responses is an increased daily excretion of sodium.
Physical factors such as plasma colloid osmotic pressure (COP) and renal arterial blood
pressure have an important influence on sodium excretion. The most important physical
factor related to long term achievement of sodium and water balance is the arterial blood
pressure in the kidneys. An increase in blood pressure to the kidney results in an
increased excretion of sodium and water, known as pressure natriuresis. The kidney's
response to changes of arterial pressure defines the salt sensitivity of individuals.
2.1.3.5 The kidneys as a common element in salt sensitive hypertension
Salt-sensitive hypertension is characterized by a cluster of renal, hormonal, and metabolic
derangements that might favour the development of cardiovascular and renal
complications (Ferri et al., 1998). Although there is strong evidence that the kidney is
the final common pathway in the long-term control of pressure, the initial abnormality of
the kidney need not be intrinsic to the development of hypertension (Cowley et al.,
1995). A variety of factors can lead to a reduction of renal excretory function and result
in hypertension. These include circulating hormones such as angiotensin IT, aldosterone,
atrial natriuretic peptide, renal sympathetic nerve activity which have an important
influence on the pressure-natriuresis relation and lead to various forms of hypertension.
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In a series of studies carried out in anaesthetized rats it was found that changes of various
hormones and the renal sympathetic nerves influence the acute pressure-natriuresis
relation and thereby predict salt sensitivity to long-term changes in sodium intake
(Cowley, 1997). Factors that resulted in salt-sensitive forms of hypertension are high
aldosterone, high adrenergic hormones, high COP, Iow prostaglandin E2, low kinins, and
low atrial natriuretic factor. These are largely sodium- retaining hormones and paracrine
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Figure 1 : Analysis of arterial pressure regulation In non-salt sensitive essential
hypertension and salt-sensitive essential hypertension (Guyton, 1981).
The reasons for the failure of the kidneys of essential hypertensive people to excrete salt
and water at normal pressure levels is unknown (Guyton, 1981). Figure 1. illustrates
arterial pressure regulation in non-salt sensitive essential hypertension. In both instances
the curves are shifted to the right, to a much higher pressure level than for normal people.
In the case of the person with non salt-sensitive essential hypertension, the arterial
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pressure does not increase significantly when changing from normal salt intake to high
salt intake. However, in patients who have salt-sensitive essential hypertension, the high
salt intake exacerbates the hypertension. The reason for the difference between nonsalt-
sensitive essential hypertension and salt-sensitive hypertension is presumably structural
or functional differences in the kidneys of these two types of hypertensive patients
(Guyton,1981).
2.1.4 Animal models in Hypertension
Humans are the only mammals to spontaneously develop hypertension. Unfortunately,
there are no animal models that are "naturally" hypertensive because all mammals
continually lose fluids due to evaporation and obligatory excretion by the kidney.
Over the past 50 years various animal models of hypertension have been developed.
Characteristics ofan ideal animal model
nAn ideal animal model should have five characteristics:
i) mimic the human disease,
ii) allow studies in chronic, stable disease,
iii) produce symptoms which are predictable and controllable,
iv) satisfy economical, technical and animal welfare considerations and,
v) allow measurement of relevant cardiac, biochemical and hemodynamic parameters.
n(Doggrell and Brown, 1998).
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Many species of laboratory animals have been used in hypertension research. Some of the
procedures that have been reported to produce sustained hypertension in experimental
animals are listed in Table 4. The majority of genetic and induced forms of experimental
hypertension have been studied in rats. The major advantage of this species seems to be
the availability of strains with different genetic predispositions to the occurrence or
induction of experimental hypertension.
2.1.4.1 Rat Models of Hypertension
The use of rat models is rational, due to the costs of maintenance and also due to the fact
that a wide range of techniques may be used to explore certain relevant parameters.
However, the use of animal models is limited by ethical concerns and opposed opinions
within the community on the necessity for the use of animals in research. Some rat
models develop terminal illness and death due to certain procedures and this is inevitable
if these rats are valid models of human diseases with high morbidity and mortality.
The study of hypertension, or to be more specific, salt-sensitive hypertension has been
helped by the introduction of inbred rat models, especially the Dahl/Rapp salt sensitive




In the 1950s, the effects of a high salt diet on the blood pressure were studied (Meneely
and Bail, 1958). They remarked that "there was a marked degree of individual variation"
in the blood pressure response to salt ingestion.
Rapid evolution of salt sensitivity is strongly supported by the observations of Dahl and
Shakow's animal model (Dahl and Shackow, 1964). They showed that artificial selection
of rats could, in only three generations, produce one strain with extreme salt sensitivity
and another with extreme salt resistance.
Dahl and colleagues noted that an unselected population of Sprague-Dawley rats
demonstrated striking variation in the effect of a high salt intake on blood pressure. To
test if this was related to genetic factors, his group examined the effect of selective
breeding on the blood pressure response to salt.
First the blood pressure response to high dietary salt intake was determined in an
unselected group of rats. Matings were produced between a pair with the lowest change
in blood pressure with salt loading, the ancestors of the salt-resistant (SR) strain, and
another pair with the greatest increase in blood pressure, the ancestors of the salt-
sensitive strain.
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Table 3: Procedures that produce hypertension (Ganong, 1989).
1. Interference with renal blood flow (renal hypertension)
a. Constriction of one renal artery ; other kidney removed
(one-clip, one-kidney Goldblatt hypertension)
b. Constriction of one renal artery; other kidney intact
(one-clip, two-kidney Goldblatt hypertension)
c. Constriction of aorta or both renal arteries
(two-clip, two-kidney Goldblatt hypertension)
d. Compression of kidney by rubber capsules, production of perinephritis, etc
2. Interruptions of afferent input from arterial baroreceptors (neurogenic hypertension)
a. Denervation ofcarotid sinuses and aortic arch
b. Bilateral lesions ofnucleus of tractus solitarius
3. Treatment with corticosteroids
a. Deoxycorticosterone and salt
b. Other mineralocorticoids
4. Partial adrenalectomy (adrenal regeneration hypertension)
5. Genetic
a. Spontaneous hypertension in various strains of rats
b. Salt-induced hypertension in genetically sensitive rats
The first generation of these selective matings demonstrated a significant difference in
the blood pressure-raising effects of high salt intake. This process was continued for two
more generations, at which time there was no overlap between SS and SR responses to
the blood pressure-raising effects of high dietary salt. In this way 2 strains of rats that
were either susceptible or resistant to the hypertensive effects of a high salt diet were
developed.
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These rats were termed the DaW (SS/Jr) and DaW (SR/Jr). Harlem Sprague Dawley, Inc
has maintained S and R rats with a program of strict inbreeding since receiving these
strains from Dr John Rapp in 1986. By 1991, the inbreeding of both these strains for
more than 50 generations resulted in a very high level of genetic homogeneity within
each strain and, as a result, very reliable physiological responses.
2.1.4.2.2 Characteristics of Dahl rats
The salt sensitive Dahl rats develop severe and fatal hypertension when fed high salt
diets, whereas salt resistance rats do not develop such a severe hypertension upon salt
loading. Also when fed normal salt diets, the salt sensitive rats become hypertensive,
demonstrating that this is a model of genetic hypertension, with the extra feature of salt
sensitivity (Rapp, 1982).
Simchon et al. (1991) suggested that initiation of hypertension induced by 8% dietary salt
for 4 weeks in Dahl S rats was due to an increased cardiac output (CO) accompanied by
an expansion of blood volume. Also, they found that progression of hypertension after 8
weeks on this salt diet was associated with an increase in total peripheral resistance
(TPR), whereas CO decreased to below normal.
A recent study conducted in this laboratory collaborated with the findings of Simchon et
al. (1991). When the DaW S rat is fed a high salt diet (8% NaCI), mean arterial pressure
typically increases by 20 mmHg within 24 hours and continues to rise to about 170
mmHg or higher around 2 weeks (Channa, unpublished). The initial rise in arterial
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pressure appears to be triggered by sodium retention. The animal gains about 7% in body
weight and plasma volume and cardiac output increases significantly. Later, the cardiac
output returns towards control values and the hypertension is maintained by increased
peripheral resistance.
The age at which a high salt diet is started partly determines the magnitude of the blood
pressure response in Dahl S rats. When Dahl salt sensitive rats were placed on a high salt
(8% NaCl) diet at weaning (21-23days of age), they rapidly developed hypertension and
all died by the 16th week of salt feeding. If high salt feeding was delayed until 3 months
of age, the hypertension developed less rapidly and blood pressure went to about 185
mmHg by 16 - 20 weeks (Dahl et al., 1968).
Renal injuries appear in DaW S rats after 2 to 3 weeks of a high salt diet; the lesions are
of a focal nature and comparable to malignant hypertensive renal disease seen in humans
(Karlsen et. al., 1997). When DaW salt sensitive rats are placed on a high salt diet early in
life, they typically die after 4 to 8 weeks (Rapp and Dene, 1985). The reason for the rapid
development of end-stage renal disease in the DaW S rat is unknown, however it has been
suggested that the glomeruli are exposed to the damaging effect of an elevated pressure
caused by a decrease in afferent arteriolar resistance (Azar et ai., 1979). There is a
widespread misconception that Dahl salt sensitive rats become hypertensive only when
placed on a high NaCI diet. In fact, on normal rat chow that contains 1% NaCI rats
become markedly hypertensive, but it just takes a longer time (months instead of weeks)
(Sustarsie et ai., 1981).
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2.1.4.2.3 Suitability of Dahl salt sensitive rats in salt-sensitive hypertension
Understanding salt-sensitive hypertension in humans has been helped by the introduction
of the inbred rat models, especially the Dahl/Rapp salt-sensitive and salt-resistant rats.
The development of hypertension and heart failure in the DahllRapp salt-sensitive rat can
be controlled by titration of the amount of salt in their diet (Dahl and Heine, 1975).
Therefore, when one considers a NaCl-related type of hypertension such as essential
hypertension in humans or in the Dahl salt sensitive rat, it is usually the combination of a
high-NaCl diet plus a kidney with slow Na excretion which brings about a rise in blood
pressure.
In Dahl S rats the rate of hypertension development is partly related to the daily salt
intake. A 4% NaCl diet brings about 30% rise in blood pressure by the 11 th week of
feeding while in the same period the 8 % NaCI diet induces a 70% rise in blood pressure
(Dahl et aI., 1968). This allows for the Dahl S rat to serve as a model of hypertension
which can be studied both in its acute and chronic forms.
In conclusion, the Dahl S rats have many features in common with human essential
hypertension and provide a unique experimental model with which to unravel




In 1993, a group of scientists in Japan "accidentally" discovered a new hypotensive
peptide while screening a panel of peptides extracted from a pheochromocytoma. This
new regulatory peptide was discovered by monitoring its stimulating action on platelet
cAMP production. Since it was derived from the adrenal medulla, it was termed
"adrenomedullin".
Their findings was reported in a seminal paper entitled "Adrenomedullin : a novel
hypotensive peptide from human pheochromocytoma" (Kitamura et aI., 1993), and since
this report, several hundred papers have been published regarding the regulation of its
secretion and multiplicity of its actions.
2.2.2 Structural Identification of Adrenomedullin
Human ADM consists of 52 amino acids and has one intermolecular disulphide bond
(Kitamura et aI., 1993). Figure 2 shows the amino acid sequence ofhuman ADM.
The carboxy-terminal tyrosine residue is amidated, a feature that is often observed in
other biologically active peptides. The sequence homology of ADM with human cGRP
and amylin is not so high, although they share a 6-residue ring structure formed by an
intramolecular disulphide linkage and the C-terminal amide structure (Kitamura et aI.,
1993). Therefore, adrenomedullin is thought to belong to the cGRP superfamily.
..
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Figure 2: Amino acid sequence of human ADM.
(http://wwwfantom3.com/Eric/gallerypages/AMseq.htm)
Porcine adrenomedullin is nearly identical to the human peptide, with only a single
substitution (glycine for asparagine) at position 40 (Kitamura et al., 1994). Rat ADM
consists of 50 amino acids similar to, butdistinct from human ADM. Compared with the
human peptide, 2 residues have been deleted and 6 residues substituted in rat
adrenomedullin (Figure 3). The ring structure and carboxy-termina1 amide structure, both
of which are essential for the hypertensive activity of ADM, are consistent between
speCIes.
2.2.3 Synthesis of Adrenomedullin .
Adrenomedullin is synthesized as part of a larger precursor molecule, termed
preproadrenomedullin. As shown in Figure 4, human preproadrenomedullin consists of
185 amino acids, which include the adrenomedullin sequence (Kitamura et al., 1993).















Figure 3 : A comparison of the amino acid" sequences of adrenomedulIin from different
species (Hinson et al., 2000).
immediately adjacent to the carboxy-terminal Tyr residue of adrenomedullin. Gly-X-Y,
where X and Y are basic amino acid residues, can serve. as a signal for carboxy-tenninal
amidation (Kitamura et al., 1993).
.",_. •• '.. ',., .~......-v ~..... , • '., • "'. • . ~'~., -.
Figure 4: Schematic structure ofhuman adrenomedullin precursor, and amino acid
sequence of human proadrenomedullin amino-tenninal 20 peptide (PAMP). (Kangawa et
aI., 1996).
Preproadrenomedullin contains a 21-amino acid N-tenninal signal peptide, designated
proadrenomedullin N-terminal 20 peptide or PAMP (Kitamura et aI., 1993). It has also
been suggested that a further biological active peptide, tenned adrenotensin, may be a
product of the adrenomedullin gene (Gumusel et aI., 1995).
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2.2.4 Genomic structure of adrenomedullin
The gene for human adrenomedullin was isolated from a human genomic library and its
structure was determined (Ishimitsu et aI., 1994). The gene encoding
preproadrenomedullin is termed the adrenomedullin gene and has been mapped and
localized to a single locus of chromosome 11. The genomic DNA of human
adrenomedullin consists of 4 exons and 3 introns, and the 5'-flanking region contains
TATA, CAAT and GC boxes (Ishimitsu et al., 1994). There are several binding sites for
activator protein-2 (AP-2) and a cAMP-regulated enhancer element.
Studies have shown that the adrenomedullin gene is expressed in a wide range of tissues.
The highest levels of adrenomedullin mRNA expression were seen in the adrenal
medulla, ventricle, kidney, and lung but recent studies show that it is highly expressed in
endothelial cells than even in the adrenal medulla (Sugo et al., 1994). Although
adrenomedullin is widely regarded as being a product of vascular endothelial cells, it
appears that not all endothelial cells synthesize the peptide. This is noticeable in the rat
adrenal gland, where adrenomedullin immunostaining is absent in the vascular
endothelial cells and smooth muscle cells (Satoh et aI., 1996). It is still questionable as to
whether some cell types store adrenomedullin. However, evidence shows that the
secretory granules in the pancreas store adrenomedullin (Martinez et aI., 1996), but this
has not been established in other endocrine tissues.
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2.2.5 Circulating adrenomedullin
After numerous studies to measure plasma adrenomedullin levels, it was concluded with
some certainty that the normal plasma concentration of adrenomedullin is in the range of
1 - 10 pM, with most values between 2 and 3.5 pM (Kohno et al., 1996; Lewis et aI.,
1998).
Evidence suggests that the major circulating form of adrenomedullin is a carboxy-
terminal glycine-extended peptide, which is converted to mature adrenomedullin by
enzymatic amidation (Kitamura et aI., 1998). The plasma concentration of glycine-
extended adrenomedullin (iAM) is 2.7 ± 0.18 pM, and mature adrenomedullin (mAM) is
0.48 ± 0.05 pM (Kitamura et aI., 1998).
Adrenomedullin has also been measured in rat plasma, using an antiserum that recognizes
both rat and human forms of adrenomedullin (Sakata et aI., 1994). Adrenomedullin levels
measured in rat plasma were comparable to that measured in man, at 3.6 ± 0.34 pM.
Numerous studies have been conducted to measure circulating adrenomedullin in disease.
In many cardiovascular disorders, plasma adrenomedullin is reported to be elevated,
suggesting that increased adrenomedullin is part of the homeostasis of blood pressure,
released to compensate for elevated blood pressure (Hinson et aI., 2000).
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2.2.6 Receptors and Signal Transduction
Adrenomedullin binding has been demonstrated in most cell types and tissues of the body
(Hinson et aI., 2000). Adrenomedullin receptors have always been closely associated
with receptors for the related peptide, CGRP. Although CGRP receptors mediate some of
the effects of adrenomedullin, recent studies show the presence of receptors with a higher
affinity for adrenomedullin than CGRP (Ishizaka et aI., 1994; Eguchi et aI., 1994).
Examination of specific 125I-adrenomedullin binding sites showed high levels of abundant
and specific binding for ADM in rat heart, lung, spleen, liver, skeletal muscle and spinal
cord (Owji et al., 1995).
Adrenomedullin seems to have little affinity for receptors for the other two members of
the peptide family, calcitonin (Disa et aI., 1997) and amylin (Vine et al., 1996).
The effects of adrenomedullin may be mediated by both specific adrenomedullin binding
sites and by CGRP binding sites. The actions of adrenomedullin have been inhibited
using CGRPs-J7 and adrenomedullin22_52, a CGRP1 receptor antagonist and an
adrenomedullin receptor antagonist, respectively. However, neither of these peptides is
especially potent or specific.
Two receptor clones have been proposed to have specific adrenomedullin binding
properties, L1 (Hanze et aI., 1997) and the CRLR-RAMP2 combination (Buhlmann et
aI., 1999). However, there are experiments in which neither of these candidates appears
to account for specific adrenomedullin binding.
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Evidence reflect that the major effect on adrenomedullin-stimulated cells is an elevation
of cAMP (Takahashi et aI., 1997; Coppock et al., 1999), which is characteristic of the
calcitonin family of peptides. Therefore, the initial mechanism of action of
adrenomedullin (and CGRP) is in most cases via G-protein linked receptor activation of
Gs, adenylyl cyclase, and protein kinase A (PKA). However, data suggest alternative
signal transduction pathways for ADM may exist.
Adrenomedullin has also been shown to activate other signal transduction mechanisms
including K+- ATP channels (Sakai et al., 1998) and c-fos expression (Moody et al.,
1997). However, a lot more needs to be learnt about adrenomedullin signalling before its
mechanisms of actions can be conclusively determined.
2.2.7 Tissue distribution of Adrenomedullin
Radioimmunassay of plasma and tissue extracts, immunohistochemical studies and
detection of tissue ADM mRNA has made it possible to investigate the potential sites of
synthesis and distribution of this ubiquitous peptide.
The adrenal medulla was found to display a high concentration of immunoreactive
adrenomedullin. High concentrations of immunoreactive adrenomedullin was also found
in the atrium, lung, pancreas and small intestine whilst the brain cortex and heart
ventricle displayed smaller amounts. Table 4 summarizes the distribution of
immunoreactive ADM in human tissues.
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Table 4 : Regional distribution and plasma concentration of immunoreactive ADM in
humans. Results are expressed as fmol/mg wet tissue. Plasma concentration of ADM is
expressed as pg/ml. (Kangawa et aI., 1994).
Adrenal medulla 47.7 ± 26.1
Pheochromocytoma 92.1 ± 101.6
Heart atrium 1.68 ± 1.58













Brain cortex 0.53 ± 0.10
Thyroid gland 0.31±0.15
Plasma 0.28 ± 0.12
17.2 ± 6.4
Jougasaki et al. (1995) demonstrated the immunohistochemical localization of ADM in
glomeruli, cortical distal tubules, and medullary collecting ducts but not in proximal
tubules of canine kidney.
The concentration of immunoreactive adrenomedullin in aorta, ventricle, kidney and lung
was found to be less than 3% of that in adrenal medulla, yet high levels of
adrenomedullin messenger RNA were found in the former tissues (Kitamura et aI., 1994;
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Sakata et al., 1993). This discrepancy may be explained by the possibility that
adrenomedullin biosynthesized in these tissues may be rapidly and constitutively secreted
into the blood, or may function as an autocrine or paracrine regulator (Bean et aI., 1994).
In contrast, adrenomedullin synthesized in the adrenal medulla is thought to be stored in
the granules and secreted in the regulatory pathway. Therefore, the biosynthetic and
excretory pathways of adrenomedullin may be different in each tissue.
2.2.8 Brief overview of the biological actions of Adrenomedullin
Initially, adrenomedullin was thought to be exclusively a vasodilator, however recent
studies suggest that its more than simply a vasodepressor. This hormone has been shown
to have a wide range of actions, from regulating cellular growth, actions on the
cardiovascular system, central nervous system, and endocrine system.
2.2.8.1 Hemodynamic actions
Ishiyama et al. (1993) studied the hemodynamic effects of human adrenomedullin, using
anesthetized rats. They found that administration of adrenomedullin resulted in a
significant decrease in total peripheral resistance accompanied by a fall in blood pressure.
Their findings indicated that human adrenomedullin is a potent vasodilator and may have
some role in the regulation of blood pressure. The hypotensive activity of adrenomedullin
is comparable to that of CGRP, which has been established as one of the potent
vasorelaxants, indicating that adrenomedullin may serve as a hypotensive peptide that
controls circulation (Kitamura et aI., 1995).
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These effects were also noticeable in a study using hypertensive rats (Khan et aI., 1997).
Furthermore, the hypotensive effect of adrenomedullin on mean arterial pressure in the
anesthetized rat is not inhibited by CGRP8-37, indicative that this effect is not mediated
via CGRP receptors (Nandha et aI., 1996).
Adrenomedullin was found to lower vascular resistance in rat lung, heart, kidney and
adrenal gland (He et al., 1995). Ebara et al. (1994) demonstrated that adrenomedullin
caused an increase in renal blood flow (RBF), suggesting it to be a potent vasodilatory
peptide with a diuretic effect. They concluded that adrenomedullin may play an important
role in the regulation of renal function.
A study usmg the isolated perfused rat lung preparation, showed that human
adrenomedullin caused a decrease in preconstricted vascular tone with no effect on
resting tone (Heaton et aI., 1995).
Adrenomedullin appears to have direct effects on the heart and coronary circulation and
was found to exhibit inotropic effects by increasing heart contractility via a specific
adrenomedullin, Ca2+ -dependent mechanism in the rat heart (Szokodi et aI., 1998).
2.2.8.2 (;rolVth
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Numerous studies suggest the possibility of adrenomedullin being an autocrine/paracrine
growth factor in tumors and normal cells. One study found that Swiss 3T3 cells produced
correctly processed adrenomedullin, which is regulated by cytokines and growth factors
(Isurni et aI., 1998).
Also, adrenomedullin and CGRP stimulated DNA synthesis and cell proliferation in rat
vascular smooth muscle cells (Iwasaki et aI., 1998). These results provide strong
evidence for a growth-promoting effect of adrenomedullin, possibly mediated via cAMP.
Adrenomedullin has also been identified as an important factor in embryogenesis and
differentiation (Montuenga et aI., 1997; Yotsumoto et aI., 1998). However, the exact
effects of adrenomedullin on growth and proliferation are debatable, and further research
is needed to clarify this phenomenon.
2.2.8.3 Endocrine Effects
2.2.8.3.1 The pituitary
In studies conducted, adrenomedullin was found to inhibit ACTH from rat anterior
pituitary cells in a dose-dependent manner and also attenuated CRR-stimulated ACTH
production (Samson et aI., 1995). Samson et al. (1995) also demonstrated the ability of
angiotensin IT to antagonize the actions of adrenomedullin. Another study found that
intravenous infusion of adrenomedullin into conscious sheep, caused significant
reduction in plasma ACTH which continued to fall after cessation of the infusion (Parkes
and May, 1995), suggesting that adrenomedullin plays a role in inhibiting ACTH release.
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2.2.8.3.2 The adrenal gland
Adrenomedullin was found to affect the secretory activity of the adrenal cortex in both rat
and human (Nussdorfer, 1996). Furthermore, it was demonstrated that adrenomedullin
significantly inhibited aldosterone production in rats (Yamaguchi et al., 1996).
Also, several different adrenal tissue preparations were used to investigate the effects of
adrenomedullin on steroid secretion, which have produced conflicting results. Whilst
some studies report the inhibitory effect of adrenomedullin on angiotensin IT-stimulated
aldosterone secretion in man (Andreis et aI., 1997), others reported that adrenomedullin
stimulates aldosterone secretion (Hinson et al., 1998). In intact rats adrenomedullin also
causes an increase in adrenal blood flow (He et aI., 1995). This observation that
adrenomedullin also acts as a vasodilator in the adrenal vascular bed suggests that
adrenomedullin can stimulate corticosterone secretion by the rat adrenal. Studies
conducted on intact perfused rat adrenal preparations suggest that this is the case (Kapas
and Hinson, 1998 ; Andreis et aI., 1997).
A study conducted of adrenomedullin on adrenal catecholamine release in dogs (Masada
et aI., 1999), revealed that adrenomedullin did not affect catecholamine levels, however
further studies need to be conducted in this field.
2.2.8.3.3 The pancreas
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The effects of adrenomedullin on the pancreas appear to be contradictory. An initial
study reported the stimulatory effects of adrenomedullin on insulin secretion from
isolated rat islets (Mulder et al., 1996). A later study revealed the inhibitory role of
adrenomedullin on insulin secretion (Martinez et ai., 1996).
2.2.8.4 Renal Effects
Studies have reported the role for locally produced adrenomedullin in tubular function.
Intrarenal adrenomedullin administration in anesthetized rats increased renal blood flow,
urine output, and urinary Na+ excretion in a dose-dependent manner, which is indicative
of direct preglomerular and postglomerular arteriolar effects (Ebara et al., 1994). In the
anesthetized rat, intrarenal adrenomedullin infusion lead to increases in renal blood flow,
glomerular filtration rate (GFR), Na+ excretion, and urine flow (Hirata et ai., 1995;
Haynes et ai., 1995). These effects were not inhibited by CGRP8-37. Mean arterial blood
pressure was lowered and RBF, GFR, and urine flow were raised by bolus administration
ofadrenomedullin (Vari et aI., 1996)
Studies have been performed in the rat model of heart failure. It was found that
intravenous infusion of a low dose of adrenomedullin to normal rats or those with heart
failure led to significantly increased urine volume and Na+ excretion without changing
GFR, RBF or any other hemodynamic parameter (Nagaya et ai., 1999). High dose
adrenomedullin infusion decreased mean arterial pressure and increased cardiac output in
both rat groups. They also showed that adrenomedullin reduced right ventricular systolic
pressure in heart failure rats with pulmonary hypertension.
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Hinson et al. (2000) suggested that adrenomedullin could also play a regulatory role in
the endocrine function of the kidney. A study revealed that adrenomedullin elevated
plasma renin levels in rats, a response thought to be secondary to the hypotensive action
of adrenomedullin (Jensen et aI., 1997). Furthermore adrenomedullin also stimulates
intrarenal renin release where renin release was shown to be from juxtaglomerular cells
(Jensen et aI., 1997).
2.2.8.5 Respiratory effects
Adrenomedullin was found to cause pulmonary vasodilation as well as inhibiting
bronchoconstriction in rats (Yang et aI., 1996). Also, adrenomedullin may have an anti-
inflammatory role in the lung (Zhang and Phan, 1996).
2.2.8.6 eNS effects
The exact sites of adrenomedullin action in the eNS still remain unclear. However, the
paraventricular nuclei and supraoptic nuclei are the most likely sites of action, since
previous studies have shown adrenomedullin immunoreactivity and binding sites exist
here (Satoh et al., 1995).
Adrenomedullin is present in the central nervous system and may have some role in the
modulation of salt appetite, thirst, and sympathetic activity. Samson and Murphy (1997)
found that intracerebroventricular administration of ADM inhibits salt appetite in the rat
possibly through a central action that mirrors the natriuretic effects of the peptide in the
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kidney and the adrenal effects to inhibit aldosterone secretion. Earlier, Murphy and
Samson (1997) reported that adrenomedullin inhibits water drinking in the rat.
The central hypertensive actions of adrenomedullin in conscious rats are dose-dependent
and not antagonized by CGRP8-37 (Saita et al., 1998). Direct effects of adrenomedullin
on sympathetic nerve activity in conscious rats showed that adrenomedullin induced an
increase in preganglionic sympathetic discharge (Saita et al., 1998). To further
understand the CNS effects of adrenomedullin, further attention needs to be addressed in
this area.
2.2.9 Adrenomedullin and Hypertension
Due to the high specificity and sensitivity of the radioimmunoassay for adrenomedullin, a
study was conducted to determine plasma levels of immunoreactive adrenomedullin in
healthy volunteers and in patients with hypertension (Kitamura et aI., 1994). The patients
were grouped according to the WHO classification of stages of hypertension, on the basis
of their clinical characteristics. The plasma concentrations of immunoreactive
adrenomedullin in patients with severe (WHO stage ill) hypertension was significantly (p
< 0.05) higher than that in normotensive volunteers and in patients with mild (WHO
stage I) hypertension. In addition, the mean plasma level of immunoreactive
adrenomedullin in patients with mild and moderate hypertension showed a nonsignificant
tendency to increase in comparison with that in normotensive individuals. Thus, the
augmentation of plasma adrenomedullin in patients with hypertension seems to be
progressive and proportional to the severity of the disease.
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Ishimitsu et al. (1994) studied plasma levels of adrenomedullin in patients with essential
hypertension or chronic renal failure. Compared with healthy individuals, plasma
adrenomedullin was increased by 26% (p < 0.05) in hypertensive patients without organ
damage and by 45% (p < 0.005) in those with organ damage. The increase in plasma
adrenomedullin levels was more prominent in patients with renal failure than in patients
with hypertension. Adrenomedullin levels were also found to show intimate correlation
with noradrenaline (norepinephrine), atrial natriuretic peptide and cAMP levels in plasma
(Sugo et al., 1994). Thus, it may be postulated that plasma adrenomedullin levels
increase in association with changes in sympathetic nervous activity and body fluid
volume in hypertension and renal failure (Kitamura et aI., 1995).
The plasma level of adrenomedullin in patients with congestive heart failure was 5.4 ±
0.3 pmolfL, which was significantly higher than that of healthy control individuals (p <
0.05)(Tanaka et aI., 1994).
To date, plasma adrenomedullin levels have been found to be elevated in patients with
hypertension, renal failure and congestive heart failure. Considering adrenomedullin's
potent hypotensive and vasodilatory effect, adrenomedullin could be expected to
counteract the arteriolar vasoconstriction found in these disorders and may therefore be of
benefit.
In conclusion, it is possible that adrenomedullin plays a role in the pathophysiology of
hypertension (Chao et aI., 1997). Plasma levels of AM are found to be elevated in
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In conclusion, it is possible that adrenomedullin plays a role in the pathophysiology of
hypertension (Chao et al., 1997). Plasma levels of AM are found to be elevated in
hypertension in proportion to the severity of blood pressure elevation and to the degree of
renal impairment (Ishimitsu et al., 1994; Kohno et al., 1996). Studies in animal models of
hypertension have demonstrated that short and long term adrenomedullin infusion lowers
arterial blood pressure (Khan et ai., 1997) as does gene delivery of human AM gene in
spontaneously hypertensive rats (Chao et al., 1997).
2.3 STRUCTURAL ORGANIZATION OF THE ADRENAL GLAND
2.3.1 Gross Anatomy
The paired adrenal glands occupy the superior borders of the kidneys. They are composed
of two parts viz. an outer cortex and an inner medulla - which function as two separate
glands. The adrenal cortex is responsible for secreting the steroid hormones, which
participate in the regulation of mineral balance, energy balance, and reproductive
function. The adrenal medulla secretes the hormone epinephrine and norepinephrine,
which complement the sympathetic nervous system in the "tight or flight" reaction.
2.3.2 General Histology
2.3.2.1 Adrenal cortex
The cortex consists of three concentric zones:
• zona glomerulosa - thin, outermost zone
• zona fasiculata - thick, middle zone
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• zona reticularis - thin, inner zone
Figure 5 : Rabbit adrenal gland (H&E stain)
(http://arbl. cvmbs. colostate. edu/hbooks/pathphys/endocrine/adrenal/histo_overview)
Figure 5 shows an example of the three cortical zones and medulla in a section of a rabbit
adrenal gland. The cells in the adrenal cortex consist of three concentric zones. The
outermost zone is named the zona glomerulosa. The cells present in this zone appear
columnar in shape and are arranged in irregular cords.
Figure 6 is a picture showing the zona glomerulosa from the adrenal of a cat and a rabbit.
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Rabbit Cat
Figure 6: The zona glomerulosa region of the adrenal cortex of the rabbit (left) and the
cat (right) ((H&E stain)
(http://arbl. cvmbs.colostate. edu/hbooks/pathphys/endocrine/adrenal/histo_cortex)
The middle zone, which is termed the zona fasciculata, is the largest of the three zones.
The cells present in this zone are polyhedral in shape, are abundant with lipid droplets,
and are arranged in straight cords that radiate toward the medulla. Cortical capillaries are
usually prominent within the fasiculata.
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_ r;lomerulosa reticubris _
Figure 7 : The zona fasiculata region of the rabbit adrenal gland (H&E stain)
(http://arbl. cvmbs.colostate.edu/hbooks/pathphys/endocrine/adrenal/histo_cortex)
Figure 7 above shows the zona fasiculata in a rabbit adrenal. The innermost zone of the
cortex is the zona reticularis. These cells are arranged in cords that project in different
directions and anastomose with one another. Figure 8 below shows the reticularis
centrally, with part of fasiculata on the left and the medulla on the right.
Figure 8 : The zona reticularis of the rabbit adrenal gland (H&E stain)
(http://arbl. cvmbs. colostate. edu/hbooks/pathphys/endocrine/adrenal/histo_cortex)
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2.3.2.2 Adrenal Medulla
The most abundant cell in the adrenal medulla is the chromaffm cell. These cells are
columnar in shape and rather basophilic. At high magnification, they are seen to have a
granular cytoplasm due to hormone-containing granules. They are arranged in clusters,
usually around medullary veins, as seen below in a picture of rabbit adrenal (Figure 9).
The adrenal medulla is richly innervated by preganglionic sympathetic fibers and small
numbers of sympathetic ganglion cells can be observed in the medulla. Ganglion cells are
round or polygonal with prominent nuclei.
Figure 9: The medullary region of the rabbit adrenal gland (H&E stain)
(http://arbl. cvmbs. colostate. edu/hbooks/pathphys/endocrine/adrenal/histo_medulla)
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2.3.3 Vascularization and Innervation
A connective tissue capsule encases the adrenal gland and it is this capsule that extends
septae into the substance of the gland. This organ is richly vascularized and capsular
blood vessels, nerves and lymphatics penetrate along with the connective tissue septae.
Histological examination of the adrenal gland reveals a rich vasculature.
Ramifying the. surface of the gland are numerous small arteries from several sources,
which penetrate the gland in two ways:
• Cortical arteries and arterioles branch into capillary beds within the cortex to
supply that area, then coalesce into veins at the corticomedullary junction.
• Medullary arteries and arterioles penetrate the cortex without branching, then
form capillary beds in the medulla.
Blood from both cortical and medullary veins empties through a single large central vein,
which leaves the adrenal and anastomoses with either the vena cava or renal vein.




During the course of this study, several specialized physiological techniques were
employed. This subchapter aims to discuss very briefly the advantages, disadvantages
and more importantly the choice of the method used. Techniques discussed include
immunohistochemistry, non-invasive blood pressure recordings as well as the use of the
AIN-76 nutrtional diet.
2.4.1 Priciples of Immunohistochemistry
2.4.1.1 Intoduction
Immunohistochemistrty, is a technique that employs the use of antibodies to locate
antigens in tissues. Because molecules are restricted in distribution to specific cell types,
the ability to identify molecules through antigenic sequences has become a powerful
technique In diagnostic surgical pathology (True, 1990). The goal of
immunohistochemistry is a more precise characterization of cells, infectious agents, and
macromolecules that nonimmunologically based histochemical stains can usually
provide. Bancroft and Stevens (1990) defined immunohistochemistry as a technique
which identifies cellular or tissue constituents (antigens) by means of antigen-antibody
interaction, with the site of antibody binding being identified either by direct labeling of




Any molecule that has generated an antibody response is called an antigen. The part of
the antigen that reacts with a given antibody is the specific antigenic determinant or
epitope. A molecule possesses several different potential epitopes, although an antibody
will bind with only one specific epitope. Although most antigens are proteins, any type of
chemical can be antigenic.
Antigenicity
Antigenicity refers to the presence of antibody binding activity. Because antigenicity is
dependent on the physicochemical nature of the three-dimensional structure of the
antigen, it is influenced by the chemical and physical forces of tissue processing (True,
1990). "Optimal" antigenic preservation refers to retention of antigenicity that is
identifiable with available antibodies. The various procedures of tissue handling which
may alter antigenicity are (True, 1990):
1. Auotlysis
Ischemia and cell death, which occur after tissue is devitalized, initiate the release of
lysosomal proteolytic enzymes. By metabolizing cell components, these enzymes,
irreversibly alter their molecular structure and alter their antigenicity. To mInImIZe
autolysis of devitalized tissue, the endogenous proteolytic enzymes must be rapidly




The purpose of fixation is threefold: inactivation of autolytic mechanisms, with retention
of tissue architecture; immobilization of molecules to prevent their artifactual
relocalization to other cell compartments or to prevent diffusion from the tissue; and
increase in tissue rigidity for possible sectioning without embedding (True, 1990).
The degree of loss of antigens from tissue varies with the fixative. Protein losses of up to
6%, 8%, and 10% have been reported with 10% formalin, Camoy's solution, and ethanol,
respectively (Mays, 1984). Conditions that accelerate fixation - heat, agitation, and the
more rapid delivery of fixative to tissues, such as by perfusion - optimize localization of
antigens. The degree to which antigenicity is altered depends on both fixative and
antigen. However, neither formaldehyde nor ethanol changes the antigenicity of peptide
hormones to readily available antibodies (True, 1990). Furthermore, the length of fixation
correlates with the degree of alteration of antigenicity (Battifora and Kopinski, 1986).
The conditions of fixation also affect antigenicity, therefore fixation in an isotonic
solution at neutral pH optimizes retention ofnative antigenicity (True, 1990).
The most common protocols and agents for fixation are:
Freezing - Freezing optimizes retention of native antigenicity and, when done rapidly,
precisely localizes antigen.
Alcohols - Alcohols and acetone fix antigens and enzymes by denaturation. Antigenicity
is altered minimally.
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Aldehydes - Aldehydes fix by primarliy covalently cross-linking proteins between a and
E-amino groups.
Osmium - Osmium tetroxide, which is a tetrapolar compound, cross-links lipids and
proteins through chelation of multiple sites (Bullock, 1984).
3. Embedding
Both the conditions of embedding and the type of embedding medium potentially alter
antigenicity. Heat which is necessary for infiltration of tissues by paraffin can potentially
affect antigenicity. The type of embedding material may also have a differential affect on
retention of molecules. Common embedding methods are:
Freezing - Freezing provides a sufficiently rigid structure for sectioning; its advantage
over other media is that it alters antigenicity the least.
Paraffins - The paraffins are complex hydrocarbons that are selected for their melting
point, hardness, and ease of removal. The great advantage of paraffin is that it enables
cutting of many sections with efficiency.
Plastics - Plastics possess greater hardness, and therefore facilitate thinner sectioning.
Most of the plastics, as embedding media, can be removed after sectioning to regain
antigenicity. (True, 1990)
2.4.1.2.2 Antibodies
Antibodies belong to the class of serum proteins known as immunoglobulins. They are
glycoproteins that bind with high affinity and specificity to antigens. Antibodies are
formed in the humoral immune system by plasma cells, the end cell of B lymphocyte
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transformation after recognition of a foreign antigen. There are five types of antibody
found in the blood of higher vertebrates, IgA, IgD, 19B, IgG and IgM. IgG is the
commonest and the most frequently used antibody for immunohistochemistry. The IgG
molecule is composed of two pairs of light and heavy polypeptide chains linked by
disulphide bonds to form a Y shaped structure. The terminal regions of each arm vary in
amino-acid sequence and are known as 'variable domains'. This variability in amino acids
provides specificity for a particular epitope and enables the antibody to bind specifically
to the antigen against which it was raised.
Polyclonal Antibodies
These are produced by immunizing a host animal with a purified specific molecule
(immunogen) bearing the antigen of interest. The animal will mount a humoral response
to the immunogen and the antibodies so produced can be harvested by bleeding the
animal to obtain immunoglobulin-rich serum.
It is likely that the animal will produce numerous clones of plasma cells (polyclonal),
with each clone producing an antibody with a slightly different specificty to the variety of
epitopes present in immunogen. Some of these antibodies may cross-react with other
molecules and will need to be removed by absorption with the appropriate antigen.
Polyclonal antiserum maximises the number of antibodies bound to a molecule that has
little repetitiveness of epitopes (True, 1990). Polyclonal antisera are quicker and more
readily available than monoclonal antibodies.
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Monoclonal Antibodies
Monoclonal antibodies are produced by clones of plasma cells. Antibodies from a given
clone are immunohistochemically identical and react with a specific epitope on the
antigen against which they are raised.
The development of the hybridoma technique, by Kohler and Milstein (1975), to produce
monoclonal antibodies has revolutionised immunohistochemistry by increasing
enormously the range, quality and quantity of specific antisera. This approach to antibody
production has dramatically increased the number of antisera available for
immunohistoochemistry and has allowed for further evolution with the ability to identify
more antigens in paraffin sections (Bancroft and Stevens, 1990). However, on
comparison with polyclonal antibodies, they have a lower sensitivity.
2.4.1.3 Affinity
Affinity is the binding strength of an antibody to a specified antigen and is characterised
as an affinity constant. The derivation of the affinity constant is as follows:





For immunohistochemistry, the higher the affinity constant, the better the antibody,
because the antibody is more likely to remain bound to the antigen sought during the
procedure (True, 1990).
2.4.1.4 Antibody-antigen binding
The amino acid side chains of the variable domain of an antibody form a cavity which is
geometrically and chemically complementary to a single type of antigen epitope. The
analogy of a lock (antibody) and key (antigen) has been used, and the precise fit required
explains the high degree of antibody-antigen specificty seen. The associated antibody and
antigen are held together by a combination of hydrogen bonds, electrostatic forces and
van der Waal's forces.
2.4.1.5 Detection Systems




2.4.1.5.1 Direct Fluorescent Antibody Methods
Principle
In this method a known antigen in a section or smear of tissue is localized by virtue of its
combination with fluorescently labelled molecules of its antibody. However, this method
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is not capable to localize antigens at low concentrations in a tissue and due to this lack of
sensitivity, it is not often used.
2.4.1.5.2 Indirect Fluorescence Techniques
Principle
In indirect methods it is possible to identify either antigens or antibodies in a tissue. The
reagent common to the procedures of this type is a fluorescently labelled antiserum to
immunoglobulin: an anti-antibody. This technique is superior to the direct method
however some antigens occur in tissues in quantities too small to be detected by the
indirect fluorescent antibody method. Greater sensitivity is achieved when the label is a
histochemically demonstrable enzyme rather than a fluorochrome.
2.4.1.5.3 Enzyme-labelled Antibody Methods
Principle
In these techniques antibodies are labelled by conjugation with enzymes. Numerous
methods employing enzymes as tracers for immunohistochemistry have been developed
over the past two decades.
These techniques are based on the principle that enzymes may be attached to antibodies
either directly or indirectly and that sites of antibody attachment to tissue sections can be
demonstrated by the addition of an appropriate enzyme substrate, cofactors that are
necessary for enzymatic activity, and a chromogen or capture reagent that is deposited at
sites of antibody attachment (Nakane, 1975).
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Horseradish peroxidase (HRP) is the most widely used enzyme and in combination with
the most favoured chromogen, i.e. 3,3'-diaminobenzidine tetrahydochloride (DAB), it
yields a crisp, insoluble, stable, dark brown reaction end product which is capable of
enhancement (Graham and Karnovsky, 1966).
2.4.1.5.3.1 Direct Method
This is the simplest and shortest method of antigen detection (Bancroft and Stevens,
1990). The primary antiserum is conjugated directly with a tracer molecule such as the
enzyme horseradish peroxidase. It is the least sensitive method.
2.4.1.5.3.2 Indirect Method
In this technique, the primary unconjugated antibody is allowed to bind to the antigen in
the tissue section. A second tracer-conjugated antibody, raised in another animal host and
specific for the animal and immunoglobulin class of the primary antibody, is applied to
the section and allowed to bind to the primary antibody. This method is more sensitive
than the direct technique and is still rapid and inexpensive.
The advantage of these techniques over the indirect fluorescent antibody method lies in
its higher sensitivity. However, the next method described is much more sensitive than
the indirect enzyme-labelled antibody procedure. Its sensitivity is considerably greater
than that of any other immunohistochemical technique and this was the method employed
during our study.
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2.4.1.5.4 Unlabelled Antibody-Enzyme Method
Principle
This method localizes the prImary antibody with a secondary antibody, termed the
"bridging" antibody. When incubated with the section in excess, this secondary antibody
"bridges" the primary to a tertiary complex, which contains the label. The tertiary
peroxidase-antiperoxidase (PAP) complex is developed in the same species of animal as
is the primary antibody for successful" bridging". A schematic representation of this















___ = Epitope of Primary IgG
PO = Horseradish Peroxidase
Figure 11 : Immunostaining method - Peroxidase-antiperoxidase (True, 1990).
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The PAP complex is thus a valuable and versatile immunohistochemical reagent for the
detection of the sites of binding of anti-antibodies. Several studies have demonstrated that
the PAP technique has a higher sensitivity than the direct and indirect conjugate methods
or the unlabelled antibody bridge technique (Azar, 1988)
2.4.1.6 Quantitative Immunohistochemistry
Quantitative immunohistochemistry is the determination of the concentration of an
antigen at the light-microscopic level within tissues or cells or at the electron-microscopic
level within cell compartments, in either relative or absolute units (True, 1990).
The concentration of an antigen is most easily accessible by estimating relative visual
intensity of a chromogenic label. Successful quantitative immunohistochemistry should
satisfy the following conditions (True, 1988) :
• All antibody-antigen and enzyme-substrate reactions must be conducted under
conditions where binding is saturated.
• The distribution of reagents must be homogenous.
• The matrix (tissue or embedding medium) and the antigen density should have a
predictable effect on immunostaining intensity.
• Quantification should be done objectively.
2.4.1.7 Variables and Controls in Immunohistochemical procedures
The interpretation of any immunohistochemical staining procedure is dependent on a
number of imp flant variables, which include the specificity of the immunological
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reagents, the sensitivity of the detection system, the adequacy of control studies, and the
experience of the observer (Azar, 1988)
2.4.1.7.1 Choice of Technique
The methodology and choice of technique in immunohistochemistry is most frequently
governed by the nature of the antigen to be detected. The benefits of using the indirect
technique are the short time required to complete the staining and the low cost of the
antisera.
2.4.1.7.2 Antiserum Specificity
The specificity of the antiserum is of paramount importance in the interpretation of an
immunohistochemical reaction. For optimal staining to occur it is necessary to use the
primary specific antiserum at the correct dilution since incorrect dilutions can give rise to
false negative results.
2.4.1.7.3 Blocking Endogenous Enzymes
If enzymes similar to those used as the tracer are present in the tissue they may react with
the substrate used to localise the tracer and give rise to problems in interpretations
(Bancroft and· Stevens, 1990). False positive reactions produced in this way can be
eliminated by inhibiting the endogenous enzyme activity prior to staining.
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Incubation in absolute methanol containing 0.3% hydrogen peroxide for 10-30 minutes at
room temperature has been reported to produce an almost complete abolition of
endogenous peroxidase activity, without affecting the immunoreactivity of antigens.
2.4.1.7.4 Controls
It is essential that any method using immunohistochemical principles includes controls to
test for the specificity of the antibodies involved. Polyclonal antibodies usually contain
antibodies specific for several antigenic determinants on the antigen and, as many related
molecules have components in common, false positive results can be obtained.
For immunohistochemical staining to be claimed as specific it must be shown firstly, that
no staining occurs in the absence of the primary antiserum and secondly, that staining is
inhibited by adsorption of the primary antiserum with the relevant antigen prior to its use,
but not by adsorption with other related or unrelated antigens.
In practice, to evaluate the results of immunohistochemical staining, the following
immunological and non-immunological specificity controls are usually undertaken.
Negative control: This involves either the omission of the specific primary antiserum
from the staining schedule or the replacement of the specific primary antiserum by an
immunoglobulin that is directed against an unrelated antigen. The immunoglobulin>.
be of the same class, source and species.
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Positive control: As the absence of staining in a test section does not necessarily imply
that the antigen is not present, the use of a section ofknown positivity is advisable.
Absorption control: The ideal negative control is to demonstrate that immunoreactivity is
abolished by pre-absorption of the specific primary antiserum with purified antigen, but
not by preabsorption with similar molecules. This type of control is necessary in the
characterisation and evaluation of new antibodies. It is rarely used in diagnostic work,
where well characterised antisera are available, because it is wasteful of reagents and
expenSIve.
2.4.2 NON-INVASIVE BLOOD PRESSURE MEASURE~ENTS
In 1733, Stephen Hales became the first person to measure arterial pressure directly. He
did this when he sacrificed his horse in his back yard and measured the height of a
column of blood extending from the carotid artery into a glass tube from the time of
~annulation until the horses' death. This was the first step in the development of direct
and indirect means with which to measure arterial pressure. Table 5 represents the
various landmarks which led up to our current means of noninvasive blood pressure
measurement.
With the proper tools anyone can record mean arterial pressure reliably in anaesthetized
rats, but when blood pressure is to be monitored repeatedly in awake rats. over several
weeks or months, then the technical difficulties become almost insurmountable (Bunag,
1984).
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Three methods are commonly used to measure blood pressure in the rat and mouse: tail
cuff, telemetry and indwelling catheter. Table 6 briefly compares the advantages and
disadvantages of these three techniques.
Table 5 : First blood pressure measurements.
(http://www.mcphu.edu/continuing/cme/medicine/med_study.htm)
• Late 1700s ,Stephen Hales. First direct arterial pressure measurement.
• Early 1800s Poiseuille introduced mercury hydrodynometer. Smaller height of
column needed.
• 1846 Carl Ludwig. Added a float to the mercury manometer with a connecting
arm which inscribed arterial pulse wave on a moving smoked drum, gave
permanent record.
• 1880s. First noninvasive measurements. VonBasch recorded systolic BP needed
to obliterate the arterial pulse.
• 1889 vonHemholtz improved upon vonBasch instrument.
• 1896 Riva-Rocci. Wrap around inflatable rubber cuff
• 1900s vonRecklinghausen increased width of the cuff from 5 to 13 cm
• 1905 Nikolai Sergeyevich Korotkoff described the sounds heard with a
stethoscope placed over the brachial artery below the Riva-Rocci-
vonRecklinghausen cuff during slow deflation.
2.4.2.1 Indirect Measurement in Awake Rats
Direct measurements are undeniably more accurate, yet most chronic studies still rely
almost exclusively on indirect measurements (Bunag, 1984). Over the past three decades,
the tail-cuff method has been the method of choice for indirect measurement. Of these
two methods direct recording is often continuous and more accurate, but also technically
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more demanding. By contrast, indirect tail-cuff measurements, though less accurate, do
not require surgery and can be repeated almost indefinitely.
Table 6 : Comparison of the tail-cuff, telemetry and indwelling catheter measurement
techniques. (from Deng, 1998)
Less accurateTAIL CUFF Relatively inexpensive
Noninvasive
Fast in obtaining systolic Immobilization stress
pressure imposed by
restraint
INDWELLING Accurate and direct In Invasive
CATHETER measunng SBP, DBP, and
MAP
physical
Long term and continuous
More economical than
telemetry
TELEMETRY Accurate for SBP, DBP, Very expensive in costs of
purchasing runmng and
maintaining the instrumentDirect measurement
Allows chronic, long term
and continuous monitoring Invasive
MAP
2.4.2.1.1 The Tail-Cuff Method
Bunag (1984) aptly stated in a review that "a rat's tail is a slender appendage of which the
weight of so much research in hypertension hangs". Accuracy of measurement with any
indirect method is greatly influenced by the length of the arterial segment that is
compressed, which in turn depends on a balance between width of the occluding cuff and
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diameter of the extremity on which the cuff is applied (Bunag, 1984). Most methods
employ preheating to dilate the tail vessels, but the amount of preheating required varies
from one rat to another and is therefore difficult to standardize.
Two reasons argue against the use of a tail cuff as a blood pressure measuring method
(Deng, 1998). (1) When conducting measurements, the tail cuff must be immobilized and
the animal heated. Thus, the blood pressure can be stress induced. If two groups of rats
being compared respond differently to this stress, the blood pressure differences between
them will have an added element of environmental artefact. (2) The tail cuff measures
systolic pressure, but does not reliably give diastolic and mean arterial pressure
measurements.
2.4.2.1.2 Validation of tail-cuff measurements
In studying a large number of rats simultaneously, the tail-cuff method can be used as a
screening tool initially, but a direct measurement should be helpful afterwards. Validation
is usually done by comparing indirect measurements with those recorded directly from an
arterial catheter (Bunag, 1984).
2.4.3 NUTRITIONAL DIETS
In 1973, the Ad Hoc Committee was formed by the Council of the American Institute of
Nutrition (AIN) to develop recommendations on nutritional methodology which would
serve as guidelines for scientists who have limited experience in experimental nutrition
techniques (American Institute ofNutrition, 1977).
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2.4.3.1 Recommended Diets for Rats
2.4.3.1.1 Cereal Based Diets
The National Institute of Health developed an open formula cereal-based diet in 1972. It
has been found to be satisfactory for reproduction, lactation, and maintenance of both rats
and mice.
2.4.3.1.2 Purified Diet
In developing a formula for a purified diet, the committee decided that the diet should not
contain quantities of vitamins and minerals highly in excess of the requirements for rats
and mice as set forth by the committee on Animal Nutrition National Research Council.
The mineral mixture was designed to contain all trace elements known to be required by
rats and mice when maintained under conventional conditions, and when used with a
conventional protein source. In the proposed vitamin mix, the amounts provided are
considered to be several times the requirements, and several vitamins are higher to allow
for possible losses during mixing and storing.
The formula for the diet is shown in Table 4. The diet contains 50% sucrose - this
primary carbohydrate was selected in view of the fact that no one-carbohydrate source
could be considered ideal for all studies. However, high sucrose diets are cariogenic, and
after 6 months, teeth of all rats can be expected to be carious, although this does not seem
to otherwise affect their general health and performance.
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The Committee believed that the AIN-76 Purified Diet meets the nutritional requirements
of rats and mice and supports, growth , reproduction and lactation comparable to those
from cereal based diets.
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3. MATERIALS AND METHODS
3.1 EXPERIMENTAL ANIMALS, HOUSING AND TREATMENTS
A total of 44 male weanling rats of Dahl salt resistant (DSR) and Dahl salt sensitive
(DSS) strains, weighing about 35-40g each, were bred in the Biomedical Resource Centre
(BRC) at the University of Durban-Westville, South Africa. Thereafter they were divided











The animals were individualized by ear notching. Rats were given deionised water ad
libitum and during the course of the baseline week, which was a week prior to
commencement of the experimental procedures, these weanlings were maintained on
ordinary rat chow containing 0.4% NaCl.
They were housed in individual metabolic cages (Nalgene) in a temperature (22 QC),
humidity (55%) and day/night controlled environment in the BRC. All experiments were
conducted in accordance with the guidelines for the care and use of animals approved by
the Ethics Committee of the University ofDurban-Westville.
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3.2 DIETARY TREATMENT- AIN 76 diet
The animals were maintained on the AIN 76 diet which is recommended for optimal
growth since it contains all essential nutrients (in correct proportions) to ensure normal
physiological functioning of the rat (American Institute of Nutrition recommended Diet,
1977). However, a 1% NaCl and 8% NaClload was included into the diet, and these two
loads of dietary NaCl could be considered as either "normal" or "high", respectively.
3.2.1 Diet Composition
Specifications of the American Institute for Nutrition were strictly adhered to. Table 7
shows the ingredients and their respective concentrations in the basal diet.
Table 7: American Institute ofNutrition recommended diet (1977)
Choline Bitartrate 0.2 4g
DL - Methionine 0.3 6g
AIN 76 Vitamin Mix 1.0 20g
AIN 76 Mineral Mix 3.5 70g
Alphacel 5.0 lOOg
Corn Oil 5.0 lOOg




The two diets were similar in all respects except for the NaCI content. For the preparation
of the 1% NaCI diet, 109 ofNaCI per kg of diet was included into the mixture. Similarly,
for the 8% NaCI diet 80g ofNaCI per kg of diet was included in the mixture.
Table 8 and Table 9, shows the vitamin and mineral mixtures of the diet.









Retinyl palmitate (Vitamin A)

















To make up 1000 g
Table 9: AIN 76 Mineral Mix
Calcium Phosphate Dibasic
Potassium Citrate Monohydrate 220.2 660 g
Potassium Sulphate 52.0 156 g
Magnesium oxide 24.0 72g
Magnesium Carbonate (43-48%Mn) 3.5 10.5 g
Ferric citrate (16-17% Fe) 6.0 18 g
Zinc carbonate (70% ZnO) 1.6 4.8 g
Cupric carbonate (53-55% Cu) 0.3 0.9 g
Potassium iodate 0.01 0.03 g
Chromium potassium sulphate 192.0 1.65 g
Sucrose, finely powdered To make 1000g 576 g
3.2.2 Diet Preparation
All the diets were prepared m the Department of Physiology and Physiological
Chemistry. Three kilograms of mineral mixture was calculated to be sufficient to last the
entire duration of the project, and this was prepared initially.
The diets were made in 2x2kg batches on a weekly basis i.e. 4 kilograms of high sodium
diet as well as a normal sodium diet were prepared weekly.
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Mixing of the diet was performed manually, with dietary components being added in
increasing quantities so as to ensure the homogeneity and consistency of the diet. A
similar procedure was followed during the preparation of the mineral mix. Alphacel,
which is a very amorphous substance, was first stabilized to corn oil before addition to
the diet. After manual mixing, each 2 kg batch was transferred to a mechanical food
mixer (Gyphron) for 30 minutes to ensure equal distribution of all the individual
components in the mixture. The final diets were stored and refrigerated at goC.
3.3 FOOD CONSUMPTION AND BODY WEIGHTS
Feeding of the animals was performed at 9:00am from Monday to Friday. The prepared
diets were dispensed in 25g quantities into the food trays. At the end of five days, a load
of 75g was dispensed to accommodate for the weekend. Daily food consumption was
calculated as the difference between the quantity remaining in the food trays from the
initial quantity (25g). As the rats grew, the quantity of the diet was increased to 30g, but
the same principle for monitoring food consumption was used.
Body weights were monitored twice a week with the use of an electronic balance
(Mettler). Weight measurements and daily food consumption was monitored in the BRC.
3.4 BLOOD PRESSURE MONITORING
3.4.1 Blood Pressure Equipment
The llTC Model 31 NIBP software was used to capture noninvasive blood pressure test
recordings. The system comprises of an automatic scanner and pump, a tail cuff with a
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photoelectric sensor and amplifier to measure and count the pulse rate in the animal's tail.
The principle of operation is related to the Riva-Rocci method used in humans.
Small, medium and large sizes of restraining devices were used. This was to compensate
for the increase in mass and size during the 6-week duration of the experiment. These
restrainers are constructed of sturdy transparent, 1/4" wall acrylic, which fit the rats
snugly so as to minimize movement, which could have affected the blood pressure
values.
Restrainers allowed for the ventilation of the head at one end and protrusion of the tail
through the tail cuff at the other end. Two tail cuff sizes, lOmm and 15mm, were used
during the duration of the experiment.
3.4.2 Training Protocol
Training sessions were carried out for 5 consecutive days i.e. sessions of unrecorded
measurements using the tail-cuff method. During this period, rats were acclimatized at
28°C in restrainers for blood pressure measurements. Handling of rats, confinement in
restrainers, and repeated inflation and deflation of the tail cuff was also incorporated into
the training session. The aim of the sessions was to habituate the rats to blood pressure
monitoring conditions so that when actual recordings were taken, stress reactions would
be minimized ensuring that reliable values could be obtained.
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3.4.3 Experimental measurements of Blood Pressures
Blood pressure was measured weekly between 10hOO and 13hOO. Measurement of blood
pressures at the same time on the day of the recording was performed to minimize the
variables related to circadian rhythms. Heaters were switched on 30 minutes prior to
blood pressure measurements to ensure that a room temperature of 28°C-29°C was
maintained. Due to its sensitivity, the IT TC apparatus allows direct measurement of
systolic and mean arterial pressure without external preheating as long as the room
temperature is maintained at 28°c or above. This is 1°C above the normal 26°C-27°C
ambient temperature for rats. Therefore rats were warmed for 10 to 15 minutes at 28°C,
to make pulsations of the tail artery detectable, prior to measurements for blood pressure.
Conscious, unanaesthetised rats were allowed to enter the restrainer by manipulating the
head gate and the boot straps of the end plate. Animals were then preheated at ± 28°C for
5 minutes. Thereafter the appropriate tail-cuff was applied at the base of the tail. The
pump automatically inflated the tail cuff, which resulted in arterial blood supply to the
tail to be occluded. The cuff was then deflated and the reappearance of pulsations, as
detected by the photoelectric sensor, was taken as the systolic blood pressure. As the
pressure continued to fall, the computer stored the value of each high pulse point, which
was accepted as a mean pressure if there was no higher pulse pressure within the next two
seconds. The end point selection is automatic for systolic, heart rate while the diastolic
values are automatically computed using the equation: Diastolic = (3 mean - systolic)/2.
The computer is programmed to commence the test when maximum cuff pressure is
achieved and to end the test at a designated termination point. Also, this model has an
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artifact filter to reduce the problem of artifacts due to movement. The results were
displayed as data plots and summary data of systolic, diastolic and mean blood pressure
and heart rate on the computer screen. The test infonnation was in 2 fonns - plots of
analog wavefonns and digital values (Figure 12).
Blood pressure was calculated from the average of three readings obtained while each
animal was resting and motionless but alert. Blood pressures were detennined weekly,
with a final measurement taken at 6 weeks of age. Validation of the method was
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Figure 12 : Typical tail pulse recording using the II TC BP monitor
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3.5 TISSUE SAMPLE COLLECTION
After the desired experimental duration (6 weeks) had expired, the rats were fasted
overnight, and sacrificed the following morning. Animals were anaesthetised with
sodium thiopentone (30 mglkg) and the adrenal glands from all animals were excised and
immediately placed in 10% buffered neutral formalin.
3.6 MICROTECHNIQUE
3.6.1 Tissue Processing
Processing comprises of many steps viz. fixation, dehydration, clearing and infiltration.
The different chemical solutions, alcohols, clearing reagents and supporting mediums
used together with the stipulated duration are tabulated below.
1. FIXATION 10 % Buffered neutral formalin 24 hours
70 % alcohol 1 hour
80 % alcohol 1 hour
95 % alcohol 1 hour
2. DEHYDRATION 95 % alcohol 1 hour
100 % alcohol 1 hour
100 % alcohol 1 hour
100 % alcohol 1 hour
3. CLEARING Xylene 45 minutes
Xylene 45 minutes
4. INFILTRATION Melted Paraffin 1.5 hours
Melted Paraffin 1.5 hours
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3.6.2 Embedding
After infiltration, the tissues were embedded by use of an embedding machine (Shandon
Histocentre 2).
3.6.2.1 Embedding Equipment and procedures
The equipment comprises of a paraffin tank, hot plate, cold plate, base moulds and a
warming tank.
Processed tissue specimens in cassettes were placed initially in a stainless steel holding
container in molten paraffin. Cassettes were thereafter removed and placed on the
warming tank. An appropriate base mould was selected from the prewarmer area housing
an assortment of base mould sizes. The mould was placed on the hot plate and paraffin
wax from the paraffin tank was dispensed to about a quarter of the level of the mould.
The specimen from the warming tank was orientated in the base mould, and holding the
tissue in the desired position with a pair of warmed forceps was transferred to the cold
plate section, to anchor the tissue firmly into place. Thereafter the cassette was replaced
on top of the base mould, transferred to the hot plate and filled completely with paraffin
wax. The mould was transferred back onto the cold plate for rapid chilling. After chilling
the case specimen was removed from the mould.
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3.6.3 Sectioning
Paraffin blocks were cut using a rotary microtome, at a thickness of 5~m The paraffin-
embedded serial sections obtained were immediately floated out on a constant
temperature water bath.
3.6.4 Mounting
The ribbon of sections floating on water was split into individual or groups of sections.
Sections were picked from the water bath with slides coated with poly-L-Iysine. Poly-L-
lysine is a general-purpose section adhesive without any apparent production of
background staining.
The slides were thereafter placed on a warming table (Ransom Warming plate) and then
transferred to the oven for complete drying. Slides were left overnight in an oven at 37°C
so as to allow the sections to adhere firmly to the slides.
3.6.5 Selection
Six slide specimens from each experimental group were randomly selected for
immunohistochemical staining.
3.7 Immunohistochemical Staining




After drying overnight at 37°C the slides were incubated for 5 minutes at 70°C. Slides
were thereafter deparaffinized with graded concentrations ofxylene and ethanol.
'fhefollowing concentrations ofxylene to ethanol were prepared-
(30:70); (50:50); (70:30) ; (90:10). (100% xylene). The tissue sections were ringed with
a DAKO pen (Dako Corporation, USA) which created an invisible well for the activity of
the reagents used in subsequent steps.
Endogenous peroxidase activity was blocked by incubation with 0.6 % H20 2 in methanol
for 30 minutes at room temperature. Slides were washed with 2 % BSA in TBS, 3
changes of 2 minutes each.
After washing, they were incubated with 40 III 5% goat serum (Dako Corporation, USA)
for 10 minutes at room temperature. This was to reduce nonspecific background staining.
Sections were washed with 2% BSA in TBS (2 changes of 2 minutes), slides were
incubated with 40 III rabbit polyclonal anti ADM antiserum (penninsula Laboratories,
USA) at a dilution of 1: 500 in a humidified chamber for 48 hours. The humidified
chamber was used to prevent evaporation of the antisera.
The control slides were treated with 40 III 5% non-Immune rabbit serum (Dako
Corporation, USA) for 45 minutes at room temperature. All the slides, including the
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control slides, were rinsed with 2% BSA in TBS (3 changes of 2 minutes) and thereafter
incubated with 40 III second antibody - goat-anti-rabbit HRP (Dako Corporation, USA) at
a dilution of 1: 100 for 30 minutes at room temperature.
After washing with 2% BSA in TBS (3 changes of 2 minutes), the final reaction was
achieved by incubating with 40 III fresh DAB solution for 10 minutes at room
temperature. The DAB-hydrogen peroxidase reaction is used for demonstration of
peroxidase activity. The reaction was stopped by rinsing with distilled water (3 changes
of 2 minutes.)
The sections were counterstained with Mayer's haemotoxylin for 5 minutes at room
temperature and washed with running tap water (2 changes of3 minutes).
Dehydration: the slides were hydrated and cleared through the following solutions.
70% EtOH 1 time 2 minutes
80% EtOH 1 time 2 minutes
95% EtOH 1 time 2 minutes
100% EtOH 2 times 2 minutes
Xylene 2 times 2 minutes
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The sections were immediately mounted using DPX and viewed using an Olympus
microscope. Stained sections were photographed under the microscope at different
magnifications, using a digital camera (Zeiss Auxio photomicroscope).
3.8 Quantification of adrenomedullin granules
For the quantitative analysis, three different areas in the medulla were randomly selected.
Therefore for each animal, the number of immunopositive granules within the medulla
was obtained by direct counting of granules in 18 fields using a 40X magnification. A
previous investigation conducted in this laboratory has found that the use of a
computerised programme viz. Kontron Systems 300, was not extremely selective in its
quantitative analysis, therefore a manual counting method was employed (Hariram,
unpublished).
3.9 Statistical Analysis
Values are expressed as mean ± standard deviation. For statistical analysis, the GraphPad
Instat V3.00 program was used, including I-way ANOVA and Turkey-Kramer multiple
comparison test. Comparison between groups was performed using Student's unpaired t
test and Kolmogorov and Smirnov assumption test.
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4. RESULTS
4.1 PHYSICAL AND BEHAVIOURAL OBSERVATIONS
Four animals did not survive the 6 week experimental period and have not been included
in the data analysis. The number of rats surviving at each time interval is given in Table
10. One of these subjects was from the Dahl salt resistant lines and the remainder from
the Dahl sensitive strain, although all animals were maintained on the high (8% NaCl)
diet. It is evident that the high (8% NaCl) diet was more severe to these rats.
Some of the experimental rats on the 8% NaCI diet displayed facial abrasions and
experienced bleeding from their noses. Their movements within the metabolic cages were
rigid and lethargic on comparison with the slightly friskier rats maintained on the 1%
NaCI diet.
Table 10: Number of Dahl salt resistant (DSR) or Dabl salt sensitive (DSS) rats
surviving on Normal (1% NaCl) or High (8% NaCl) Salt Diets.
\\ {'l'I~ .. on Hit,t BSR on BSS 011 BSR on I>SS on






















4.2 FOOD CONSUMPTION, BODY AND ORGAN WEIGHTS
The results for the average weekly food consumption are tabulated in Table 11 and
graphically represented in Figure 13. In the DSS lines, the first 4 weeks showed a gradual
increase in food consumption. Weeks 1-2 displayed a low dietary intake and this was
attributed to a period of adjustment of the rats to their new environment (metabolic cages)
as well as the diets (salt diets). A steady increase in food consumption is noticeable
during weeks 2 to 4, however while this trend continued in Dahl sensitive rats on 1%
NaCl, the DSS on 8% NaCl showed a steady decline in the remaining two weeks. This
was probably a result of the degree of severity pertaining to the hypertensive state
becoming severe and these animals became weak, stopped growing and lost weight.
Therefore, at the culmination of the experiment, the final mean body weights of the DSS
rats on a high salt diet (241 ± 4.2g) was found to be lower than the DSS on a normal salt
diet (299 ± 3.7g).
Table 11: Average Weekly Food Consumption (grams)
\\ erl,s on Diet DSR on OSS on DSI~ 011 nss on
111/11 "aCI I t'!lI \aCl 8% \aCI 811,~) \aCl
1 97.00 106.58 89.70 100.58
2 103.90 112.92 86.30 103.00
3 102.10 129.92 99.20 118.75
4 102.30 135.50 103.50 130.42
5 98.30 140.75 98.33 135.00
6 99.60 136.83 104.44 100.11
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In the Dahl resistant lines, the low dietary intake in the first 2 weeks could also be
indicative of the impact of the new environment and salt diets. However, whilst a gradual
increase in food consumption was noticeable during weeks 2-4 of the DSR rats on 8%
NaCI diet, this was absent in the DSR on 1% NaCI diet. Food consumption in Dahl
resistant rats on 1% NaCl diet remained relatively constant throughout the remainder of
the experiment at ± lOOg/week. However, during weeks 2-4 of the DSR on 8% NaCl diet,
there was a steady increase in food consumption to a maximum of ± 104g/week. The
remaining 2 weeks displayed fluctuating results, with week 5 showing a decrease in food
consumption to a low of ± 98g/week, whilst week 6 showing a gradual increase to ±
104g/week. The final mean body weights of the DSR rats on 8% NaCI diet (192 ± 4.1g)
was found to be lower than the DSR on 1% NaCI (236 ± 6.0g).
The results for the average weekly mass gain are tabulated in Table 12 and illustrated in
Figure 14. The heaviest group over the 6 week experimental period was the DSS on 1%
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Figure 14 : Growth curves of Dahl salt resistant (DSR) and Dahl salt sensitive (DSS)
rats on normal (1 % NaCI) or high (8% NaCI) diets.
Page 1
Table 12: Average weekly mass gain (in grams)
\\ r{'ks on Dirt J).\·R (Ill I (I" OSS (Ill 1(1(1 OSR 011 8(1(1 OS.\' (Ill 8(10
\aCl \aCl \aCl \aCl
1 153.50 95.00 110.20 87.83
2 179.80 140.67 118.80 127.00
3 200.50 188.58 142.70 159.00
4 220.50 225.08 163.22 178.50
5 230.50 274.30 184.00 231.67
6 236.30 304.42 191.00 244.27
Table 13 contains results pertaining to body and organ weights, which include changes in
heart weightlbody weight, left ventricle weightlbody weight and paired kidney
weight/body weight ratios of Dahl rats on normal and high salt diets. At weaning (1
month old), both salt resistant (DSR) and salt sensitive (DSS) rats had similar body
weights (35-40g), but at the end of the experimental period (3 months), the DSS line
showed a significant reduction in body weight gain.
Kidney weights were higher in Dahl sensitive rats than Dabl resistant rats either on the
8% NaCI diet or 1% NaCI diet (DSS = 2.679 ± 0.09, DSS = 2.446 ± 0.05 vs DSR = 1.733
± 0.04, DSR = 1.678 ± 0.07). This increase in weights is probably due to their renal
pathology, as McCormick et al. (1989) reported that in contrast to compensatory renal
growth, sodium-induced renal growth seems to be due mainly to renal hyperplasia in DSS
rats.
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The observation that heart weights were greater in Dahl sensitive rats than Dahl resistant
rats either on high salt (8% NaCI) diet or normal salt (1 % NaCl) diet, is a result of cardiac
hypertrophy occurring concomitant with the rise in blood pressure (DSS = 1.254 ± 0.03,
DSS = 1.156 ± 0.03 vs. DSR = 0.692 ± 0.01, DSR = 0.827 ± 0.04).
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4.3 CARDIOVASCULAR PARAMETERS
The effects of a low and high sodium diets on systolic pressure, diastolic pressure and
heart rate were analyzed. All blood pressure results are tabulated in Table 14. The effects
of an 8% NaCI and 1% NaCI supplemented diet on systolic blood pressure (SBP),
diastolic blood pressure (DBP) and heart rates (HR) are shown in Figures 15,16 and 17
respectively.
The Dahl resistant rats remained normotensive on both the 1% NaCI and 8% NaCI diet
for the 6 weeks with only a moderate increase in blood pressure corresponding to their
age.
At 2 weeks, DSS rats on normal-salt (1 % NaCl) had systolic blood pressures which were
significantly increased compared to control values of the same group (120 ± 2.1mm Hg
vs 116 ± 1.9mm Hg, P < 0.05). The DSS rats treated with a high salt (8% NaCl) diet
developed Stage 1 hypertension (systolic BP 156 ± 3.4mm Hg and diastolic BP 93 ±
3.3mm Hg).
The DSS rats treated with normal NaCI (1%), at the age of 4 weeks had above normal
blood pressures (systolic BP 162 ± 7.8mm Hg and diastolic BP 106 ± 7.1mm Hg) and the
DSS on a high NaCl (8%) diet also had high blood pressures (systolic BP 162 ± 7.6mm
Hg and diastolic BP 109 ± 8.0mm Hg). These values fall under Stage 2 classification of
hypertension and were significant compared to control values of their respective groups
(p < 0.05).
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At 6 weeks, the Dahl sensitive rats on 1% NaCI had decreased blood pressures on
comparison with the 4 week interval (SBP 150 ± 7.3mm Hg and DBP 106 ± 7.4mm Hg).
The DSS rats on the 8% diet became severely hypertensive developing Stage 3
hypertension (systolic BP 174 ± 3.3mm Hg and diastolic BP 124 ± 7.1mm Hg). Both the
results were significant compared to control values of their respective group further
emphasizing sensitivity to dietary salt intake (p < 0.05).
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Table 14: Changes in blood pressure(mm Hg) and heart rate(beats/min) ofDahl Salt Resistant(DSR)
and Dahl Salt Sensitive(DSS) rats treated with normal(l% Na) and high(8% Na) diet.
Group/ CONTROL 2 JFEEKS DIET 4 H'EEKS DIET 6 rVEEKS DIET
Partlllleler
SBP DBP HR SBP DBP HR SBP DBP HR SBP DBP HR
DSR1% 128 ± 80± 459± 138± 88± 462± 128 ± 84± 474± 134* 78± 440±
Na diet 2.7 1.7 9.2 4.1 3.7 9.0 1.5 3.5 12.7 ± 3.5 3.9 10.2
co DSR8% 115± 70± 477± 127± 74± 486± 133* 92* ± 423± 132*± 82 ± 435±= No diet 2.0 3.9 8.8 4.3 4.5 11.5 ± 5.0 7.1 12.3 5.9 4.1 7.3
DSS1% 116± 77± 445± 120* 81 ± 436± 162*+ 106*+ 496* 150*+ 106*+ 481*+
No diet 1.9 1.3 18.6 ± 2.1 2.0 14.4 ± 7.8 ± 7.1 ± 12.1 ± 7.3 ± 7.4 ± 14.0
DSS8% 116 ± 78± 478± 156*+ 93*+ 461 ± 162*+ 109* 531*+ 174*+ 124*+ 487 ±
No diet 2.5 1.2 19.2 ±3.4 ± 3.3 19.8 ± 7.6 ± 8.0 ± 14.6 ± 3.3 ± 7.1 18.9
Mean±SEM
* Significant compared to control value of the same group
+ Significant compared to the respective DR group
SBP Systolic Blood Pressure
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Figure 15 : Systolic blood pressure responses of Dahl salt-resistant (DSR) and Dahl
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Figure 16 : Diastolic blood pressure responses of Dahl salt-resistant (DSR) and Dahl






















DURATION OF DIET (weeks)
Figure 17 : Heart rates of Dahl salt-resistant (DSR) and Dahl salt-sensitive (DSS) rats
on normal salt (1% NaCI) and high salt (8°J'o NaCI) diets from weaning
4.4 IMMUNOmSTOCHEMISTRY
The reaction of horseradish peroxidase with 3,3 diaminobenzidine (DAB) substrate,
resulting in a dark stain, at sites of adrenomedullin antibody binding was used to detect
and visualize the zonal distribution of adrenomedullin on paraffin sections of the rat
adrenal. Staining for the hormone was observed sporadically in the zona glomerulosa of
the adrenal cortex (Figure 19). In addition, positive immunostaining seemed to be also
present in the zona fasiculata and zona reticularis (Figure 20 and Figure 21), although
differentially distributed. However, intensity of the staining was greatly increased in the
adrenal medulla (Figures 22-27). The control adrenal specimens treated with non-
immune rabbit serum showed no ADM immunoreactivity (Fig 18).
Photographs of the adrenal medulla show cords of cells and interspersed capillaries. In
the adrenal glands of Dahl rats, the medullary parenchymal cells have ADM cells which
seem to have a regular appearance with a slightly dense core bounded by a membrane. In
addition to the appearance of ADM immunoreactive granules in the medullary region, it
was also observed that there was a tendency to accumulate around the capillaries (Figure
23).
According to the semiquantitative evaluation, the number of adrenomedullin cells seemed
greater in adrenals of rats treated with 8% NaCI than those treated with 1% NaCl.
Quantitative data obtained to support this observation is represented in Table 15 and
graphically in Figure 28 and 29. Compared with the rats treated with 1% NaCI diet, there
was an increase in the number of adrenomedullin granules in the animals treated with an
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8% NaCI diet, irrespective whether it pertained to the Dahl salt sensitive or Dahl salt
resistant strains.
Table 15: The number of adrenomedullin cells per 0.16mm2 # in rat adrenal gland tissue
after different salt treatments.
E'(!,erilllell (a! YIIIII her (~rae/rell o/11ee/1l11i11
(,'roil!' cd/vO.! fJ /11/11-'
DSR on 1% NaCI
DSS on 1% NaCI
DSR on 8% NaCI




75.13 ± 1.6 t
Results are expressed as mean ± SEM
t P < 0.0001, DSR 1% NaCI vs. DSS 1% NaCI
t P < 0.0001, DSR 8% NaCI vs. DSS 8% NaCI
# Refer to Appendix F-2
There was a 6.3 fold increase in the proportion of ADM content in the DSS rats treated
with a 1% NaCI diet when compared with DSR treated with 1% NaCI diet which is
considered extremely significant (DSR : 5.98 ± 0.3 vs. DSS : 37.85 ± 0.5). Also,
compared with the DSR rats consuming 8% NaCI diets, there was a 4.1 fold increase in
ADM content ofDSS on 8% NaCI diets which is considered extremely significant (DSR:
18.49 ± 0.5 vs. DSS : 75.13 ± 1.6). The data also revealed that adrenomedullin content
was considerably greater after the exposure to the high sodium chloride diet which is
evident graphically in Figure 30 by the skewing of adrenomedullin content in rats fed







Figure 18 : Immunohistochemical staining ofcontrol adrenal gland tissue - NON
IMMUNE RABBIT SERUM. (magnification, X 40)
(
Figure 19 : Irnmunohistochemicallocalization of ADM in zona glomerulosa cells of rat
adrenal gland tissue. (magnification, X 40)
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Figure 20 : Immunohistochemical localization of ADM in the zona reticularis region of
the rat adrenal gland tissue. (magnification, X 20)
Figures 21 : Immunohistochemical localization ofADM in the zona reticularis region of
the rat adrenal gland tissue. (magnification, X 40)
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F'PR22 :~ moaDilZilllioo ofADM around capillaries in the
1II!DOdkrnJmamy regOOm of g,bmd 1is:me..(magnifi~ X 40)
F'PRH :lrmmm~ localiza1iJioo ofADM in the medullary region ofthe rat
ardlmuaI gland tis5ue.(~~X 40)
Figure 24 : Immunohistochemical localization ofADM in the medullary region of the rat
adrenal gland tissue. (magnification, X 40)
Figure 25 : Immunohistochemical localization of ADM in the medullary region of the rat
adrenal gland tissue. (magnification, X 40)
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Figure 26 : Immunohistochemical localization ofADM in the medullary region of the rat
adrenal gland tissue. (magnification, X 40)
Figure 27 : Immunohistochemical localization ofADM in the medullary region ofthe rat
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DAHL RAT NUMBER
igure 30 : The number of adrenomedullin cells immunostained in the adrenal medulla
f Dahl salt-resistant (DSR) and Dahl salt-sensitive (DSS) rats on normal salt (1°,'0 NaCI)
and high salt (8°,'0 NaCI) diets
5. DISCUSSION
Hypertension is a complex trait with multiple genetic and environmental influences
(Kurtz and Spence, 1993). Hormones and their actions are important in the maintenance
of blood pressure and considerable evidence suggest that adrenomedullin, a recently
discovered hypotensive hormone, contributes to the control of fluid and electrolyte
homeostasis (Samson, 1999). Adrenomedullin, which is a 52-amino-acid vasodilator
peptide, was isolated in 1993 from human pheochromocytoma (Kitamura et al., 1993). It
is a known multifunctional hormone, which affects cellular growth, the cardiovascular
system, the central nervous system, and the endocrine system. In the central nervous
system, ADM may have a role in the modulation of salt appetite, thirst, and sympathetic
activity (Samson, 1999 ; Saita et al., 1998). Adrenomedullin has been measured in a wide
range of disease states and in many cardiovascular disorders, it has been reported to be
elevated, possibly suggesting that. increased adrenomedullin participates in the regulation
of blood pressure, released to compensate for elevated blood pressure (Hinson et a!.,
2000). Although the exact mechanisms by which adrenomedullin produces vasodilation
are not clearly defined, evidence suggests that it acts indirectly through NO and through
cAMP-mediated mechanisms and via the inhibition of angiotensin IT and endothelin
production (Troughton et al., 2000). Adrenomedullin also acts in the kidney in animals,
relaxing both efferent and afferent glomerular arterioles, increasing glomerular filtration,
and inducing natriuresis (Ebara et al., 1994).
Currently, it is believed that the adrenal medulla is one of the major production sites of
adrenomedullin. The adrenal medulla also produces several known regulating factors of
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aldosterone secretion such as epinephrine, norepinephrine, vasopressin and dopamine.
Whereas previous studies have reported immunoreactivity in the rat adrenal gland (Satoh
et al., 1996), little is known about the medullary secretory capacity of adrenomedullin.
The results obtained from the present study demonstrate to some extent the precise sites
of secretion of this hormone as well as the increased rate of secretion of adrenomedullin
to compensate for the elevated blood pressure.
In order to produce exaggerated and more severe hypertension in which to evaluate the
secretion of adrenomedullin, half of the rats were maintained on a high salt (8% NaCl)
diet. The Dahl rats were chosen as a model of salt-sensitive hypertension, because the
salt-sensitive rats (DSS) are selectively bred to develop hypertension after a high salt diet
while the salt-resistant strain (DSR) remain normotensive. Our results reveal that a high
salt (8% NaCl) diet is detrimental to the health of these animals, which is evident in the
fact that four animals did not survive the duration of the project. This has been known to
occur since similar results were observed in a previous study conducted by Rapp and
Dene (1985). They found that when DSS rats are placed on a high salt diet early in life,
death ensued after 4 to 8 weeks. This suggests that the time and duration of the high salt
diet determine the survival ofDSS rats.
Food consumption in the DSS strain on 8% NaCl diet decreased as the severity of the
hypertensive state increased, and these animals became weak, stopped growing and lost
weight. This observation further emphasizes the detrimental effects to a high salt diet,
which conforms to other studies which found that when DSS rats were put on a high salt
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diet early in life, they were found to become severely ill by the 4
th
week of food
consumption (Rapp and Dene, 1985).
The changes in the kidney and heart weights are consistent with a previous study which
reported that increasing salt intake resulted in marked hypertension with left ventricular
and renal enlargements in salt sensitive rats (McCormick et al., 1989). In this study, high
salt consumption also resulted in retardation in body weight gain in the DSS rats, which
are in keeping with the results of previous investigators (Somova et al., 1999; Laakso et
al., 1998) but contrasted with others who found a greater growth rate on a high sodium
diet (Channa M.L, unpublished).
Due to the fact that the DSS rats on 8% NaCl developed hypertension as early as the 2nd
week as reflected in the systolic and diastolic blood pressures suggests that DSS rats are
susceptible to the development of hypertension even at a young age which is in
agreement to the findings put forth by Dahl et al. (1968). By weeks 3-4 the DSS rats on
1% NaCl also became hypertensive further emphasizing the high susceptibility of this
strain of rat to the development ofhypertension.
The reason for the decrease in blood pressures during weeks 4-6 in DSS rats on 1% NaCI
diet, could be indicative of the maximising of the pressure natriuretic effect which has
been reported to peak at 160mm Hg (Tobian, 1995). Channa (unpublished) reported that
the initial rise in blood pressure in DSS rats appears to be triggered by sodium retention
which accompanies an increased plasma volume and cardiac output. Thereafter the
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cardiac output returns towards normal and hypertension is maintained by an increased
peripheral resistance (Wilson et aI., 1997). At the culmination of this study, no significant
differences in heart rates between both groups of Dahl salt-sensitive rats were observed
indicating that increased peripheral resistance is responsible for maintaining the elevated
blood pressure. Thus it can be concluded that even a low NaCI diet is sufficient to induce
hypertension in DSS rats as reflected by their high systolic pressures but the hypertensive
status ofDSS rats on a high NaCI diet, was further exacerbated as depicted by their high
systolic and dystolic blood pressures.
Whether the rats consumed a normal or a high salt diet, they gradually developed
hypertension (BP above 150/95 according to WHO criteria) with tachycardia at the age of
2 months. The period for the development of hypertension was reduced due to the salt
loading, with the DSS on 8% NaCI rapidly developing severe hypertension at the end of 6
weeks. Therefore this study also confirmed the genetic predisposition for the
development ofhypertension and the well known positive correlation between high blood
pressure and the sodium chloride intake in the Dahl salt sensitive model.
To date, no studies have examined quantitatively, the adrenomedullin secretory capacity
of the adrenal gland in either animal or human models of hypertension. It is known that
cells of the adrenal medulla accumulate and store their hormones (epinephrine and
norepinephrine) in granules and the data obtained from this study suggest that
adrenomedullin is also stored in secretory granules in the adrenlil medulla.
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In the present study, adrenomedullin immunopositivity was found predominantly in the
adrenal medulla, and to varying levels in the adrenal cortex or more precisely, the zona
glomerulosa and zona reticularis. In agreement with our results, Kapas et al. (1998) and
Mulder et al. (1996), found immunoreactive adrenomedullin present in the rat adrenal
medulla. However, previous studies have produced conflicting results in localizing the
presence of adrenomedullin in adrenal cortex. We observed minimal staining for
adrenomedullin in the zona glomerulosa which are in keeping with the results of previous
investigations (Kapas et aI., 1998). However, our study also found groups of two to three
cells displaying minimal-to-moderate staining for adrenomedullin in the zona reticularis,
which has not been documented previously to show immunoreactivity.
In the medulla, the pattern of staining is reminiscent of the staining of chromaffin cells
possibly suggesting that adrenomedullin is possibly synthesised by either adrenaline-
secreting or nor-adrenaline secreting cells or both. However, this study did not attempt to
establish which chromaffin subtype synthesised adrenomedullin, but a previous study
(Mulder et aI., 1996) has reported that the adrenaline-secreting cells may be a more
significant source of adrenomedullin than nor-adrenaline secreting cells, but to what
extent is unknown. In that study, which sought to determine which subtype of chromaffin
cell synthesised adrenomedullin, it was reported that the peptide was found in both
phenylethanolamine N-methyltransferase (PNMT)-positive and -negative cells. PNMT is
the enzyme that converts noradrenaline to adrenaline and is not expressed in nor-
adrenaline secreting cells. Therefore, in the study conducted by Mulder et al. (1996),
staining for adrenomedullin was less intense in the PNMT-negative cells suggesting that
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adrenaline-secreting cells may be a more significant source of adrenomedullin than
noradrenaline-secreting cells.
The present study demonstrated that on comparison with both the strains (DSR vs. DSS)
treated with 8% NaCI diet, there was an increase in the number of adrenomedullin
granules in the medullary region of the adrenal glands of DSS rats. Our current findings
show that there was a 6.3 fold increase in ADM granules of adrenal glands of DSS rats
compared to DSR rats, ingesting a 1% NaCI supplemented diet. Also, there was a 4.1 fold
increase in adrenomedullin granules of adrenal glands of DSS rats than DSR rats,
consuming an 8% NaCI supplemented diet. Importantly, the number of positive cells and
the intensity of staining also increased significantly in animals treated with 8% NaCl in
comparison to those treated with a 1% NaCI diet. This shows that the changes in ADM
content were not only strain specific but dependant on the sodium chloride intake also. It
shows both a genetic and environmental (salt) component in the ADM content increase.
The possible physiological significance underlying the aforementioned changes in the
hypertensive state are both complex and varied. Like other regulatory peptides present in
the adrenal gland, adrenomedullin affects the secretory activity of the adrenal cortex in
both the rat and human (Hinson et al., 2000). Therefore, it is possible that the high
secretion and production of adrenomedullin by secretory cells of the adrenal medulla,
may modulate the physiologic function of the adrenal cortex possibly by a paracrine
mechanism. This assumption may seem plausible since ADM and PAMP are present in
the blood, but their concentrations, under both normal and pathological conditions, are in
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the pmolar range, thereby ruling out the possibility that they act on zona glomerulosa as
circulating hormones (Richards et al., 1996).
Troughton et al. (2000) found that plasma renin activity (PRA) rose during high dose-
ADM and was accompanied by a small rise in Ang IT, whereas aldosterone levels tended
to fall consistent with the findings ofYamaguchi et al. (1996). In the adrenal glomerulosa
cells, cyclic AMP is known to stimulate aldosterone secretion, however Yamaguchi et al.
(1995) documented from their study that human adrenomedullin did not affect basal
aldosterone secretion and inhibited angiotensin IT- and potassium-stimulated aldosterone
secretion of rat zona glomerulosa cells, probably by impairing Ca2+ influx. However,
Andreis et al. (1997) suggested that not ADM, but proadrenomedullin N-terminal 20
peptide (PAMP) to be considered a physiologic inhibitor of mineralocorticoid secretion,
which may play an important role in the regulation of fluid and electrolyte homeostasis.
Previous researchers have demonstrated interactions between ADM and other hormones
(Samson et al., 1995; Mulder et aI., 1996). Aldosterone which is synthesised and released
by the zona glomerulosa cells of the adrenal cortex, is an important factor for the
regulation of blood pressure and secretion is subject to regulation by several known










Figure 31 : Schematic representation of the postulated hypotensive actions of
adrenomedullin after secretion from the adrenal medulla during hypertension
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Aldosterone, the principle mineralocorticoid, causes sodium retention and potassium
excretion by the distal nephron. It is known to act within the kidney to stimulate Na+
absorption and K+ secretion by the principal cells of the distal tubule and collecting duct.
It achieves these effects by entering the cells, binding to a receptor and inducing the
synthesis of a number of proteins. These, in turn are involved in increasing the number of
Na+ and K+ channels in the luminal membrane and in increasing the activity of Na+/K+
ATPase in the basolateral membrane. Therefore, sodium retention by the mechanism
described above, together with excretory ability, results in increased blood volume and
hence blood pressure.
The release of adrenomedullin secreted in large amounts in the adrenal medulla is
thought to inhibit the secretion of aldosterone from the zona glomerulosa. The large
amounts of ADM, if it does act as a local hormone, seems to inhibit secretion of
aldosterone from the zona glomerulosa, ensuring that sodium reabsorption is at a
minimum, possibly reducing blood volume as well as blood pressure. Figure 31 illustrates
the possible hypotensive effects ofADM after secretion from the adrenal medulla.
To compensate for the increase in blood pressure due to the salt diets, there was a co-
ordinated increase in medullary adrenomedullin. The data suggests that the adrenal gland
exhibits a compensatory response in rats with developing or full blown hypertension
manifested as a co-ordinated localized increase in adrenomedullin.
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However, it is still unclear whether systemic increases m adrenomedullin reflect an
overflow from local sites of production and action, or whether in certain conditions
increased plasma adrenomedullin has a hormonal function causing a general decrease in
vascular resistance and a fall in blood pressure (Hinson et al., 2000). Although there is
still some debate on the underlying mechanism of action of adrenomedullin, this study




The key issues that were addressed in this study, are briefly outlined as follows:
~ The Dahl Rat provided a good model for the development of hypertension, as this
study also confirmed the genetic predisposition for the development of hypertension
and the positive correlation between high blood pressure and sodium chloride in Dahl
salt sensitive rats. Our findings indicate that whether the rats consumed a normal or a
high salt diet, they gradually developed hypertension with tachycardia after 4 weeks
irrespective of the diets.
~ Salt loading was found to increase the secretion of ADM from the adrenal medulla in
DSS rats compared to DSR rats. Interestingly, DSR on a high sodium chloride diet
also had increased ADM levels compared to DSR on a low salt diet. ADM levels
therefore seemed to increase in a strain specific manner (ie. DSS vs. DSR) after salt
loading (high salt vs. low salt).
Based on the above findings, it was therefore postulated that hypertension induced by
salt loading may lead to increased secretion of ADM by the adrenal medulla of Dahl
rats which may possibly initiate a compensatory response by acting in a paracrine
manner, by inhibiting aldosterone secretion. It is possible therefore that not only is
there a genetic component to the alteration of ADM levels but also a salt dependant
component.
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Furthermore, the Dahl hypertensive rat provides a good model for the evaluation of
adrenomedullin in hypertensive states, and may therefore prove an appropriate model
for testing of drugs which may influence ADM secretion during hypertension.
~ This research was also a pioneering study in the field of immunohistochemistry in
this laboratory, and serves as a basis for establishing this method as a routine
histological technique. Immunohistochemical methods are known to be reemployed
in many fields of biological research and are regularly used in diagnostic pathology.
Therefore, this technique will prove a vital "tool" for future research, which may
require diagnostic immunopathological methods.
Recommendations for future work are briefly given below:
Some interesting questions on interpreting the immunohistochemical data can be raised
regarding the rate of secretion of adrenomedullin following hypertension. It is possible
that a more accurate assessment could have been achieved if rate of secretion was
monitored on a weekly basis rather than an overall assessment at the completion of the 6
week period. Therefore, if sacrificing of some animals on a weekly basis occurred, with
evaluation of ADM secretion being determined directly afterwards, a more concise
account of its secretion occurring concurrently with developing hypertension could have
been established.
This study has established with some clarity that increased blood pressure does result in a
co-ordinated increase in adrenomedullin, which is a known vasodilator. However its sites
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of action once released was not confirmed but it has been speculated to act on the
glomerulosa cells by inhibiting aldosterone secretion possibly by a paracrine mechanism.
Furthermore, no literature documented any occurrence of adrenomedullin in the zona
reticularis and therefore significance of the presence of adrenomedullin in the adrenal
cortex of the rat adrenal should be further explored to fully understand the role it plays in
not only hypertension, but also other diseased states if any.
In a post-genomic era, a vast array of state-of-the-art technologies are now available for
the unravelling of complex biological phenomena such as blood pressure regulation. In
the light of some of our findings, it is proposed that :
~ Transgenic technology may be employed to address the question of intra-adrenal vs.
systemic levels of adrenomedullin (by confering the production in a tissue specific
manner).
~ Protein-protein interactions be evaluated usmg coimmunoprecipitation with the
relevant antibodies, in order to shed more light on the exact role of ADM in sodium
reabsorption and transport in the kidney.
~ ADM knock-out (KO) mice be employed as negative controls, to provide direct data
on the physiological distribution and function.
The information can then be used to provide new targets for therapeutic intervention.
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BUFFERS, REAGENTS AND SOLUTIONS
1. BUFFERS
1.1 Tris Buffer (TBS) (0.05M, pH 7.6)
Dissolve 6.1g Tris (hydroxymethyt amino methane) in 50ml distilled water. Add 37ml of
IN hydrochloric acid and make up to 1 liter with distilled water. Store in refrigerator at
6°C.
1.2 Phosphate Buffered Saline (PBS) (0.02M, pH 7.0)
Dissolve 1.92g dibasic sodium phosphate anhydrous (Na2HP04), 0.92g monobasic
sodium phosphate monohydrate (NaH2P04.H20) and 5.90g Sodium chloride (NaCl) in 1
liter of distilled water. Store in refrigerator at 6°C.
2. REAGENTS AND SOLUTIONS
2.1 Hydrogen peroxide (H20 2) (0.6%)
Mix 0.1 ml 3 % H20 2 and 5 ml absolute methanol.
2.2 Goat Serum (5%)
Add 20 ml TBS to 1 ml Goat serum + 20 ml TBS. AIiquot solution in Iml eppendorf
tubes, and store in refrigerator at 6°C.
2.3 Non-immune rabbit serum (5%)
Dilute Iml Non-immune rabbit serum with 20 ml TBS. AIiquot solution in Iml eppendorf
tubes, and store in refrigerator at 6°C.
xiii
2.4 Rabbit polyclonal anti-adrenomedullin (1 :500)
Dilute 50 III Rabbit polyclonal anti-ADM with 50 III distilled water, and thereafter add to
25ml TBS. Aliquot solution in Iml eppendorftubes, and store in refrigerator at 6°C
2.5 Goat anti-rabbit horseradish peroxidase (1:100)
Dilute 0.2111 goat anti-rabbit HRP in 20ml TBS. Aliquot solution in Iml eppendorftubes,
and store in refrigerator at 6°C.
2.6 DAB solution
Dissolve 1 DAB tablet in 10 ml TBS. Aliquot solution in Iml eppendorftubes, and store
in refrigerator at 6°C, and if it becomes discoloured, discard the solution.
2.7 Hydrogen peroxide (H20 2) 3%
Add 0.1 ml H202 + distilled water.
2.8 Working DAB solution
Add 7.5 III 3 % H202 to 1 ml DAB solution. The workimg DAB solution must be
prepared freshly.
2.9 Mayer's Hematoxylin
Dissolve 50g ammonium or potassium alum in water. Add and dissolve Ig of
hemotoxylin crystals in this solution. To this mixture add 0.2g sodium iodate, Ig citric
acid, and 50g chloral hydrate. Shake well until all the components are in complete
solution producing a reddish-violet colour. Solution should be changed weekly, to ensure




WEEKLY FOOD CONSUMPTION (in grams)
GROUP RAT WEEK WEEK WEEK WEEK WEEK WEEK
NO 1 2 3 4 5 6
1 116 123 135 128 125 128
2 122 109 147 143 142 141
3 117 108 115 136 118 140
4 101 113 131 100 149 147
5 109 115 130 141 146 152
Dabl S 6 100 105 126 139 138 134
(1% 7 106 121 133 142 146 132
NaCI) 8 105 109 125 137 139 134
9 108 118 132 142 151 124
10 101 106 130 140 151 141
11 88 110 126 138 146 141
12 106 118 129 140 138 128
1 79 115 118 127 --- ---
2 100 106 125 139 133 131
3 102 103 122 130 129 51
4 96 99 112 135 137 135
5 108 108 123 134 134 ---
Dabl S 6 96 113 123 130 139 137
(8% 7 95 86 104 120 150 129
NaCI) 8 108 107 123 132 135 36
9 103 95 119 131 102 ---
10 111 106 118 130 145 125
11 105 98 120 128 145 53
12 104 100 118 129 136 104
xv
APPENDIX B-2
WEEKLY FOOD CONSUMPTION (in grams)
GROUP RAT WEEK WEEK WEEK WEEK WEEK WEEK
NO 1 2 3 4 5 6
1 84 86 87 78 83 79
2 122 120 111 119 109 110
3 78 96 90 94 89 87
4 106 115 108 107 106 116
DahlR 5 125 114 120 116 113 112
(1% 6 89 112 106 104 104 108
NaCI) 7 96 98 100 104 96 100
8 111 112 117 109 104 106
9 69 91 80 94 84 86
10 90 95 102 98 95 92
1 100 92 104 113 94 103
2 79 83 108 109 104 105
3 86 89 105 95 83 86
4 105 75 94 99 105 103
DahlR 5 105 76 105 113 109 117
(8% 6 65 83 94 95 98 114
NaCI) 7 103 90 96 106 --- ---
8 99 97 93 112 98 104
9 70 89 90 99 97 107




WEEKLY MASSES (in grams)
RAT DAY BASE Wl W2 W3 W4 IT]NO 0 LINE
1 56 81 109 161 205 238 271 301
2 61 67 107 157 201 240 295 321
3 56 79 103 146 193 224 266 287
4 58 59 79 126 181 214 250 288
5 43 57 101 150 196 230 287 319
Dabl 6 40 53 87 129 171 216 268 295
S(I% 7 43 69 105 150 208 245 298 330
NaCI) 8 39 64 97 138 183 223 271 300
9 60 77 111 157 206 236 280 305
10 40 51 80 124 171 219 276 315
11 36 46 73 114 164 190 260 297
12 38 57 88 136 184 226 270 295
1 41 64 92 109 152 177 245 ---
2 48 64 98 140 174 192 252 268
3 31 58 91 131 161 177 232 210
4 38 48 72 118 145 181 225 258
5 36 65 84 127 160 176 243 232
Dabl 6 47 70 104 142 175 201 252 275
S(8% 7 38 57 83 118 142 160 204 225
NaCI) 8 42 60 88 130 169 181 246 246
9 34 60 83 120 144 168 192 237
10 44 69 98 140 174 188 245 259
11 38 57 78 123 156 179 228 242
12 47 59 83 126 156 162 216 235
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APPENDIX C-2
WEELY MASSES (in grams)
RAT DAY BASE Wl W2 LJ W4 W5 W6NO 0 LINE
1 102 131 154 170 179 189 199 203
2 108 144 178 218 239 264 270 277
3 121 144 166 190 209 224 234 242
Dabl 4 101 146 182 210 229 245 255 260
R 5 120 156 200 226 254 278 282 290
(1% 6 55 83 123 153 184 214 230 237
NaCl) 7 57 86 125 151 179 206 220 225
8 107 130 170 202 223 243 254 265
9 65 87 106 121 130 144 147 149
10 76 100 13'1 157 179 198 211 215
1 70 99 127 134 151 171 196 204
2 76 105 141 138 164 170 173 176
3 50 81 115 112 138 153 170 198
Dabl 4 62 95 126 120 148 174 176 180
R 5 79 93 126 137 164 181 204 204
(8% 6 30 43 69 88 116 141 166 172
NaCl) 7 48 74 104 128 143 --- --- ---
8 41 56 95 113 135 164 194 202
9 40 63 93 103 125 152 184 187
10 43 73 106 115 143 163 193 196
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APPENDIXD
DATA FOR ADRENOMEDULLIN COUNTS
APPENDIX D-1
SLIDE/R 1 2 3 4 5 6
AT #
1 9 8 7 8 8 7 4 7 5 6 5 8 4 3 3 6 5 8
2 5 9 6 7 5 4 3 6 7 7 4 6 5 4 4 9 5 6
DSR 3 7 9 6 8 5 6 8 9 9 6 8 5 7 5 5 9 6 8
1% 4 8 6 5 6 5 6 6 8 5 6 6 8 6 5 7 7 6 6
NaCI 5 7 8 5 6 4 4 4 5 5 7 6 5 4 7 6 8 4 6
6 7 5 4 5 4 5 6 5 5 6 8 6 4 5 4 4 7 4
APPENDIX D-2
SLIDE/R 1 2 3 4 5 6
AT #
1 17 19 16 18 15 17 14 12 17 14 15 17 14 14 15 14 15 15
2 12 10 9 12 14 15 11 13 15 16 18 14 17 13 15 13 12 15
DSR 3 14 11 12 15 12 10 13 17 15 12 15 14 17 15 15 14 13 14
8% 4 16 14 13 14 11 17 17 14 12 13 15 12 15 15 12 13 13 14
NaCI 5 14 11 12 12 11 11 12 11 12 10 11 11 13 12 12 14 15 14
6 11 9 13 17 14 11 15 11 11 10 12 11 10 14 15 12 12 11
xix
APPENDIX D-3
SLIDEIR 1 2 3 4 5 6
AT #
1 44 37 39 38 35 42 33 35 34 35 37 35 35 35 35 37 37 33
2 35 40 46 39 44 41 33 35 38 40 48 37 38 33 41 36 41 42
DSS 3 38 35 40 35 42 41 33 37 34 39 41 43 41 38 37 36 43 45
1% 4 33 37 34 38 41 39 40 33 38 41 38 35 38 36 41 40 37 36
NaCI 5 41 38 39 35 33 37 41 38 39 44 39 41 38 40 41 37 38 41
6 35 38 33 38 40 37 36 36 35 38 35 40 32 35 38 33 35 39
APPENDIX D-4
SLIDEIR 1 2 3 4 5 6
AT #
1 78 72 84 93 78 85 87 81 74 72 74 77 70 69 74 68 68 73
2 83 74 77 72 77 69 78 76 77 78 70 69 70 74 73 70 72 70
DSS 3 69 75 79 81 78 76 68 72 75 73 72 65 70 73 69 73 70 70
8% 4 71 78 75 84 78 81 78 80 81 69 70 75 73 76 81 69 69 71
NaCI 5 81 76 75 85 83 79 73 78 79 69 70 74 75 73 70 69 70 70





ADM COUNT: DR 1%NaC vs. DS 1% NaCI
Unpaired t test
Do the means ofDR 1% NaCl and DS 1% NaCI differ significantly?
P value
The two-tailed P value is < 0.0001, considered extremely significant.
t = 53.480 with 10 degrees of freedom.
95% confidence interval
Mean difference = 31.872 (Mean ofDS 1% NaCI minus mean ofDR 1% NaCl)
The 95% confidence interval of the difference: 30.544 to 33.199
Assumption test: Are the standard deviations equal?
The t test assumes that the columns come from populations with equal SDs.
The following calculations test that assumption.
F = 4.479
The P value is 0.0627.
This test suggests that the difference between the two SDs is not quite significant.
Assumption test: Are the data sampled from Gaussian distributions?
The t test assumes that the data are sampled from populations that follow Gaussian
distributions. This assumption is tested using the method Kolmogorov and Smirnov:
XXI











Parameter: DR1% NaCI DS 1% NaCI
Mean: 5.982 37.853
# of points: 6 6
Std deviation: 0.6236 1.320




Lower 95% Cl: 5.327 36.468
Upper 95% Cl: 6.636 39.239
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APPENDIX E-2
ADM COUNT: DR 8% NaCl vs. DS 8% NaCl
Unpaired t test
Do the means ofDR 8% NaCI and DS 8% NaCl differ significantly?
P value
The two-tailed P value is < 0.0001, considered extremely significant.
t = 75.083 with 10 degrees of freedom.
95% confidence interval
Mean difference = 61.638 (Mean ofDS 8% NaCI minus mean ofDR 8% NaCl)
The 95% confidence interval ofthe difference: 59.809 to 63.467
Assumption test: Are the standard deviations equal?
The t test assumes that the columns come from populations with equal SDs.
The following calculations test that assumption.
F = 1.626
The P value is 0.3033.
This test suggests that the difference between the two SDs is not significant.
Assumption test: Are the data sampled from Gaussian distributions?
The t test assumes that the data are sampled from populations that follow
















Parameter: DR8% NaCl DS 8% NaCl
Mean: 13.492 75.130
# of points: 6 6
Std deviation: 1.241 1.582




Lower 95% Cl: 12.189 73.469
Upper 95% Cl: 14.794 76.791
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APPENDIX E-3
ADM COUNT: Comparison between all groups
One-way Analysis of Variance (ANOVA)
The P value is < 0.0001, considered extremely significant. Variation among column
means is significantly greater than expected by chance.
Tukey-Kramer Multiple Comparisons Test
If the value of q is greater than 3.958 then the P value is less than 0.05.
Mean
Comparison Difference q P value
DR 1% NaCI vs DS 1% NaCI -31.872 62.835 *** P<O.OOl
DR 1% NaCI vs DR 8% NaCI -7.510 14.806 *** P<O.OOl
DR 1% NaCI vs DS 8% NaC1 -69.148 136.33 *** P<O.OOl
DS 1% NaCI vs DR 8% NaCI 24.362 48.029 *** P<O.OOl
DS 1% NaCI vs DS 8% NaCI -37.277 73.491 *** P<O.OOl
DR 8% NaCl vs DS 8% NaCl -61.638 121.52 *** P<O.OOl
Mean 95% Confidence
Interval
Difference Difference From To
DR 1% NaCI- DS 1% NaCI -31.872 -33.879 -29.864
DR 1% NaCI - DR 8% NaCI -7.510 -9.518 -5.502
DR 1% NaC1 - DS 8% NaCI -69.148 -71.156 -67.141
DS 1% NaCI - DR 8% NaCI 24.362 22.354 26.369
DS 1% NaCI - DS 8% NaCI -37.277 -39.284 -35.269
DR 8% NaCI - DS 8% NaCI -61.638 -63.646 -59.631
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Assumption test: Are the standard deviations of the groups equal?
ANOVA assumes that the data are sampled from populations with identical SDs. This
assumption is tested using the method ofBartlett.
Bartlett statistic (corrected) = 3.584
The P value is 0.3101.
Bartlett's test suggests that the differences among the SDs is not significant.
Assumption test: Are the data sampled from Gaussian distributions?
ANOVA assumes that the data are sampled from populations that follow Gaussian
distributions. This assumption is tested using the method Kolmogorov and Smirnov:
Group KS P Value Passed normality test?
==============--===
DR 1% NaCI 0.1914 >0.10 Yes
DS I%NaCl 0.2587 >0.10 Yes
DR8%NaCI 0.2074 >0.10 Yes
DS 8% NaCI 0.1400 >0.10 Yes
Intermediate calculations. ANOVA table
Source of Degrees of Sum of Mean
variation freedom squares square
Treatments (between columns) 3 17454 5818.0
Residuals (within columns) 20 30.873 1.544
Total 23 17485




of Standard Error of


























Group Minimum Maximum From To
DR I%NaCl 5.220 7.000 5.327 6.636
DS 1% NaCI 36.280 39.280 36.468 39.239
DR8%NaCI 12.110 15.440 12.189 14.794




1. Area under microscope (X 40) = 1t r
= 22/7 X (0.45*/2i
= 22/7 X (0.225)2
=0.16mm2
* Refer to Optical Data Form.
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